We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.
Loading
8:30 AM (ET)
-
This advanced course is ideal for professionals already in business development & licensing roles, from those with limited experience (2-3 years) to highly experienced dealmakers looking to hone their skills and network with other dealmakers. This is a three day course requiring attendance on all three days.Course - Additional Fee 210BFaculty
-
This introductory-level course is designed for professionals new to the life sciences business development field or for individuals with some experience who are interested in updating their professional skills. This is a three day course requiring attendance on all three days.Course - Additional Fee 206ABFaculty
.jpg)
.jpg)
.jpg)
8:30 AM (ET)
-
This introductory-level course is designed for professionals new to the life sciences business development field or for individuals with some experience who are interested in updating their professional skills. This is a three day course requiring attendance on all three days.Course - Additional Fee 206ABFaculty
-
This advanced course is ideal for professionals already in business development & licensing roles, from those with limited experience (2-3 years) to highly experienced dealmakers looking to hone their skills and network with other dealmakers. This is a three day course requiring attendance on all three days.Course - Additional Fee 210BFaculty
-
This introductory-level course explains the path to transform a biotechnology invention into a viable start-up company, suited for biotech or MedTech entrepreneurs from the managerial, scientific, and academic communities, seeking to learn the elements required for success. This is a two day course that requires attendance both days.Course - Additional Fee 204ABFaculty
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
8:30 AM (ET)
-
This introductory-level course explains the path to transform a biotechnology invention into a viable start-up company, suited for biotech or MedTech entrepreneurs from the managerial, scientific, and academic communities, seeking to learn the elements required for success. This is a two day course that requires attendance both days.Course - Additional Fee 204ABFaculty
-
This advanced course is ideal for professionals already in business development & licensing roles, from those with limited experience (2-3 years) to highly experienced dealmakers looking to hone their skills and network with other dealmakers. This is a three day course requiring attendance on all three days.Course - Additional Fee 210B
-
This introductory-level course is designed for professionals new to the life sciences business development field or for individuals with some experience who are interested in updating their professional skills. This is a three day course requiring attendance on all three days.Course - Additional Fee 206ABFaculty
9:00 AM (ET)
-
This intermediate course explains how to effectively position your company’s story, strategy, and value proposition for institutional investors by maximizing the chances of successfully completing a significant private financing round.Course - Additional Fee 254B
-
This intermediate course is for executives and business development professionals interested in enhancing their skills in negotiations, influencing, decision-making, and game theory. Game theory will be applied to real-life pharma/biotech negotiation cases.Course - Additional Fee
-
This introductory-level course explains a systematic approach for producing a valuation and risk profile for a company or product to be used in investment rounds, mergers/acquisitions, licensing deals, or strategic development decisions in the pharma-biotech world.Course - Additional Fee 251
.jpg)
12:00 PM (ET)
-
This introductory-level course will equip early-stage biotechnology leaders with the commercialization knowledge they need to strategically position their organizations for financing success and meeting critical commercial milestones, including regulatory planning, market access pricing and reimbursement, value proposition development, and go-to-market preparation.Course - Additional Fee 254AFaculty
9:00 AM (ET)
-
Explore how the biotechnology industry can effectively engage with the U.S. Government to advance the development and deployment of medical countermeasures essential to national security. This multi-p ...Engagement Day Session
-
Business Development and Investment
-
-
This fireside chat will explore ASPR’s role in strengthening national health security, strategic preparedness, and the security of the biopharmaceutical supply chain to build a more resilient biodefen ...Engagement Day Session 205ABCModerator
9:30 AM (ET)
-
As biopharmaceutical manufacturing becomes a central focus of national security and preparedness, the U.S. government is advancing new strategies to assess and expand domestic production capacity. Thi ...Engagement Day Session 205ABCModeratorSpeakers
10:00 AM (ET)
-
After many years of research, AI-supported molecules have started entering clinical trials and the 2024 Nobel Prize in Chemistry recognized the impact of computational biology on reenvisioning the dru ...Breakout Session
-
AI and Digital Health
-
-
Join former U.S. Government staff and Washington insiders for an in-depth conversation on the evolving federal policy landscape shaping biodefense, public health preparedness, and health security. Thi ...Engagement Day Session 205ABC
.jpg)
10:30 AM (ET)
-
Join current DOD officials, defense policy experts, and seasoned government affairs professionals for a conversation focused on how the Department of Defense (DOD) is shaping the next generation of pu ...Engagement Day Session 205ABCSpeakers
11:00 AM (ET)
-
This panel of iconic healthcare and life sciences investors will share their perspectives on top areas for AI and digital health investment. Recent reports show that the number of AI deals in healthca ...Breakout Session
-
AI and Digital Health
Moderator -
-
The COVID-19 pandemic taught us many lessons, but we have yet to fully implement our collective learnings. As the virus hit, vaccines were developed at speed, yet societies across the world still lack ...Engagement Day Session 205ABCSpeakers
.jpg)
12:00 PM (ET)
-
This session aims to illuminate the cutting-edge technical approaches of AI-driven biologics drug discovery companies. Speakers will explore the ongoing R&D efforts in developing platforms and pipelin ...Breakout Session
-
AI and Digital Health
Speakers -
.jpeg.jpg)
12:30 PM (ET)
-
Company Presentation SessionCompany Presentation Session
-
Business Development and Investment
Thank you to our Company Presentation sponsors:
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.Loading
-
-
Biomanufacturing innovations have the potential for high impact, delivering benefits that span financial gains and societal advancements. These breakthroughs can drive increased efficiencies, reduce c ...Breakout Session
-
Business Development and Investment
Speakers -
.jpg)
1:00 PM (ET)
-
The most powerful health stories don’t just inform—they connect, inspire, and move audiences. By centering the real-life journeys of patients and practitioners, we create narratives that spark emotion ...Storytelling Stage Storytelling Stage (Booth #349)
-
Company Presentation
• Genti develops Engineered Tregs (EngTregs) to cure autoimmune and acute inflammatory diseases. GentiBio’s EngTreg technology is differentiated from other Treg companies, notably it includes the only ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
The Storytelling Stage is accessible to all registered attendees. You can find it located in the Exhibition Hall - Booth #349. The BIO Storytelling Stage is a showcase of the heart of BIO's priorities ...Storytelling Stage Storytelling Stage (Booth #349)
-
Company Presentation
CNCure Co., Ltd. is a pioneering biotechnology company dedicated to developing innovative and effective cancer therapeutics. Our lead candidate, CNC-101, is a bacteria-based immunotherapy designed to ...Company Presentation-
Oncology
Primary Speaker -
1:15 PM (ET)
-
Company Presentation
Atom Therapeutics is a privately held Chinese clinical stage pharmaceutical company engaged in new drug discovery and development of treatments for inflammatory and metabolic diseases. We have raised ...Company Presentation- Inflammation
Primary Speaker -
Company Presentation
We are a seed-stage biotech solving targeted delivery of mRNA-based medicines. mRNA has achieved breakthrough success with COVID vaccines, but access to most disease-relevant tissues and cell types re ...Company Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company Presentation
OncoLab Co., Ltd. is developing ANGel platform (Antibody-conjugated nanogel) for subcutaneous, sustained delivery of cancer immunotherapeutics. ANGel enables precise and durable delivery of antibodies ...Company Presentation-
Oncology
Primary Speaker -
1:30 PM (ET)
-
Company Presentation
Cartherics is a pre-clinical stage company developing cell-based products for the treatment of cancer and other intractable diseases such as endometriosis. Its technology platform is based on gene-edi ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
Eupraxia Pharmaceuticals is a late clinical stage company with multiple assets. The focus of this presentation will be to discuss Phase 2 data in Eosinophilic Esophagitis.Company Presentation- Inflammation
Primary Speaker -
Company Presentation
AUM Biosciences is a Singapore-based clinical-stage biotech company focused on developing precision oncology therapeutics. Founded in 2018, AUM is committed to addressing unmet medical needs in cancer ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
BioTechnique® is a full-service CRDMO providing cytotoxic and therapeutic sterile injectable fill-finish services. From investigational/clinical to final marketed product, BioTechnique® can provide fi ...Company Presentation- Contract Manufacturing Organization
Primary Speaker
.jpg)
1:45 PM (ET)
-
Across therapeutic areas, oncology is richest in depth of pipeline and variety of potential modalities/mechanisms of action. Of nearly 200 different products in Phase 3 alone, small molecules are now ...Breakout Session
-
Oncology
-
-
Since its inception in 1992, the FDA has greenlit nearly 300 new drugs under its accelerated approval pathway, with notable nods in oncology, Alzheimer’s disease, and amyotrophic lateral sclerosis. It ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
-
-
Artificial intelligence (AI) is already revolutionizing drug discovery and development by accelerating the identification of novel targets, optimizing molecules, and improving the efficiency of clinic ...Breakout Session
-
AI and Digital Health
ModeratorSpeakers -
-
The threat of antimicrobial resistance is growing globally as the use of higher doses and repeated courses of antibiotics drives more resistant bacteria. Yet innovation in infectious disease has been ...Breakout Session
-
Infectious Disease and Vaccines
Speakers -
-
The bioeconomy—encompassing industries that leverage biological resources, processes, and principles—spans sectors such as biotechnology, agriculture, pharmaceuticals, bioenergy, and synthetic biology ...Breakout Session
-
Biomanufacturing
Moderator -
-
The new Unified Patent Court (UPC) system in Europe has been described as a game-changer with respect to patent litigation, particularly when there are infringing activities in both Europe and the Uni ...Breakout Session
-
Intellectual Property and Legal Landscape
-
-
In a complex and ever-evolving landscape—with shifting regulatory pressures and stakeholder expectations—biotech and pharma companies must continue prioritizing transparency to build trust, maintain a ...Breakout Session
- Environmental Sustainability
-
The therapeutic use of psychedelics is no longer a pipe dream – they are on the verge of potentially transforming the way we treat brain health disorders. As companies progress psychedelic therapies i ...Breakout Session
-
Brain Health
Speakers -
-
In recent years, investors have leaned toward being “risk off” for truly innovative therapies, such as first-in-class or first-in-disease drugs, with a preference for lower-risk drug discovery opportu ...Breakout Session
-
Business Development and Investment
-
-
Today's undervalued category is tomorrow's over-crowded sector, yet newcomers are emerging. This panel will examine issues, opportunities, and approaches to dealmaking among an emerging generation of ...Breakout Session
-
Business Development and Investment
-
-
Extended reality (XR) sensory technologies enhance patient agency. This multi-purpose tool elevates patient education, provider communication, multi-dimensional therapy, and comprehensive assessments. ...Special Program
-
AI and Digital Health
Speakers -
-
Company Presentation
Clever Culture Systems (ASX: CC5) is an Australian biotechnology leader developing AI-powered microbiology solutions. Their flagship product, the Automated Plate Assessment System (APAS), addresses a ...Company Presentation- Other
Primary Speaker -
Company Presentation
bBHC developed new type of novel pluripotent stem cells which is called KHCs. This novel cell type was induced from umbilical cord mesenchymal stem cells (UC MSCs) by treatment with natural compounds ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Early drug development presents unique challenges for companies navigating the complexities of clinical programs, regulatory landscapes, and market access. This session will explore key trends impacti ...Breakout Session
-
Business Development and Investment
Sponsored by:
Speakers -
-
This panel will focus on the role of state governments in supporting life sciences innovation in the United States, including programs that are offered at the state level to support international comp ...Breakout Session
-
Business Development and Investment
Speakers -
-
Company Presentation
Saghmos Therapeutics is a privately held biopharmaceutical company developing ST-62516 (trimetazidine) to reduce the risk of Major Adverse Cardiac and Kidney Events (MACKE) after percutaneous coronary ...Company Presentation- Cardiovascular
-
Company Presentation
InnoPath Therapeutics is a drug development company developing first-in-class topical therapeutics to treat the tens of millions of people who get Actinic Keratosis and Non-Melanoma Skin Cancer every ...Company Presentation-
Oncology
Primary Speaker -
-
Innovative approaches to medicine require us to reimagine how we bring medicines to patients. This panel will explore the intersection of industry, policy, and the patient community and how collaborat ...Breakout Session
-
Value‚ Patient Access and Reimbursement
-
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
2:00 PM (ET)
-
Company Presentation
.jpg)
Founded in 2023, Gifted Molecular Science is committed to developing innovative antiviral therapies with a novel mechanism of action to combat COVID-19. With $4.0M from a strategic investor and $1.5M ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
Apertor Pharmaceuticals is creating novel molecular glues for therapeutic applications in oncology. At Apertor we have developed a new class of therapeutics to address one of the toughest challenges i ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
.png)
AstraGenomics is a biotechnology company pioneering innovative genome editing technologies. Empowered by a systematic platform integrating computational biology and lab automation, the company has dev ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Unconditional: Raising a Glass Child with a PACS1 Sibling - This film introduces the Poague Zellinger family who are facing PACS1 syndrome which affects their five year old son Finn. The phrase glass ...Storytelling Stage Storytelling Stage (Booth #349)
-
Start-Up Stadium Session
-
Business Development and Investment
-
.jpg)
.jpg)
2:10 PM (ET)
-
Start-Up Stadium-
Brain Health
-
2:15 PM (ET)
-
Company Presentation
Antibiotic resistance is one of the greatest challenges in modern medicine, driving the urgent need for alternative treatments. Bacteriophage therapy offers a promising solution by using naturally occ ...Company Presentation-
Infectious Disease and Vaccines
-
-
Company Presentation
.png)
Nanolattix utilizes its innovative, proprietary Bio-Lattix technology platform in oncology therapeutics, generating a pipeline that includes 2 monoclonal antibody ADCs, 8 bispecific ADCs, and 8 RDC dr ...Company Presentation-
Oncology
-
-
Company Presentation
Evox Therapeutics is an Oxford-based biotechnology company devoted to developing transformative therapeutics for neurological and neurodegenerative diseases by uniting engineered exosomes with next-ge ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
CinoCore provides Agentic AI solutions to clinicians that accelerate their clincial research, improve efficiency of patient management and aids on clinical decision with most up-to-date evidences.Company Presentation-
AI and Digital Health
Primary Speaker -
2:20 PM (ET)
-
Murck-Neuroscience LLC was founded as a consulting and drug development company by Prof. Harald Murck. His team has deep expertise in clinical trial design and conduct. His affiliation at the Philipps ...Start-Up Stadium
-
Brain Health
Speakers -
2:30 PM (ET)
-
Company Presentation
Remedy Plan Therapeutics is a privately held, clinical-stage pharmaceutical company transforming the field of NAMPT inhibition, with a pipeline of novel, hyperbolic NAMPT inhibitors, that never fully ...Company Presentation-
Oncology
-
-
Company Presentation
City of Hope's mission is to make hope a reality for all touched by cancer and diabetes. City of Hope has grown into one of the largest and most advanced cancer research and treatment organizations in ...Company Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company Description: Development of New Generation Selective Cannabinoid Receptor 2 Agonists for Substance Use DisordersStart-Up Stadium-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
NanoViricides, Inc. (NYSE-Amer.: NNVC) is a clinical stage nano-pharmaceutical company on the verge of revolutionizing the treatment of viral diseases, just as penicillin revolutionized the treatment ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
Huonslab is dedicated to advancing biologics research and development with a pioneering spirit. Central to its mission is the development of innovative drug delivery technologies such as HyDIZYME (rHu ...Company Presentation- Platform for Therapeutics
Primary Speaker
2:45 PM (ET)
-
Company Presentation
Bostal LLC is an enabling platform technology pharmaceutical company. Established in New Jersey in 2004, Bostal expanded its global footprint, Bostal Drug Delivery, in China in 2013. With its long-act ...Company Presentation-
Brain Health
Primary Speaker -
-
Company Presentation
We are pioneering the development of a completely new class of drugs based on the messenger RNA (mRNA). The basic principle is the use of this molecule as a data carrier for information, with the help ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
nCage Therapeutics is developing synthetic viral-like particles as vaccine candidates. The company uses de novo-designed viral particles to mount multiple antigens, allowing an increased immune respon ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
Eleva is a clinical-stage biopharmaceutical company that strives to bring novel therapies to patients in need. Partnerships are at the heart of our strategy. Our unique moss-based platform and capabil ...Company Presentation- Other
Primary Speaker -
Start-Up Stadium-
Brain Health
Primary Speaker -
3:00 PM (ET)
-
For too long, psychiatry has relied solely on clinical observation to prescribe treatments, overlooking the biological differences that impact how patients respond to medication. This trial-and-error ...Breakout Session
-
Brain Health
-
-
siRNA, mRNA, pick-your-favorite-RNA, CRISPR, ADCs, PROTACs, molecular glues, precision-meds, CAR-T, epigenetic and allosteric modulators, AI/ML-everything, tissue-selective nanoparticles, AAV delivery ...Breakout Session
-
Business Development and Investment
-
-
Cell and gene therapies (CGT) are proving their worth as life-saving treatments, from cancers to rare diseases, but bringing these innovations to the masses will require substantial advances in manufa ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
ModeratorSpeakers -
-
This session will explore how CEPI (Coalition for Epidemic Preparedness Innovations) and its global partners mobilize during an outbreak, highlighting how strategic partnerships and rapid vaccine deve ...Breakout Session
-
Infectious Disease and Vaccines
-
-
Over the past decade, European biotech has seen remarkable growth, driven by increasing early-stage investments and the creation of promising start-ups. VIB, a leading life sciences research institute ...Breakout Session
-
Business Development and Investment
-
-
While the industry is moving forward with the blending of technology and science, the legal landscape is quite different in one of the largest markets: the United States. The Loper Bright ruling this ...Breakout Session
-
Intellectual Property and Legal Landscape
Moderator -
-
Artificial intelligence (AI) and related technologies offer new avenues of drug discovery productivity never before possible. These innovative methods not only provide significant value to the biophar ...Breakout Session
-
Biomanufacturing
-
-
Healthcare AI as we know it is evolving at a rapid pace, with major tech company initiatives, overheated equity investment and the next generation of innovation fanning the flames. How can NIH and maj ...Breakout Session
-
AI and Digital Health
Speakers -
-
For biotech companies planning an IPO, navigating market dynamics, investor expectations, and regulatory hurdles is critical to success. This session brings together industry leaders to share insights ...Breakout Session
-
Business Development and Investment
ModeratorSpeakers -
-
Company Presentation
.png)
Myeloid Therapeutics is a clinical stage immunology company, engineering cutting-edge RNA technology to program immune cells to combat cancer and other deadly diseases. Myeloid is headquartered in Cam ...Company Presentation-
Oncology
Primary Speaker -
-
Fireside ChatEven now, nearly a century after her death, Marie Curie remains the only female scientist most people can name. She gained world renown at age thirty-six, when she received the first of her two Nobel ...Fireside Chat
-
Oncology
Moderator -
-
The BIO Storytelling Stage is a showcase of the heart of BIO's priorities—sharing the stories of the biotechnology industry that show who we are, who we serve, what we do, and why we do it. You'll hea ...Storytelling Stage Storytelling Stage (Booth #349)Speakers
-
In today’s global economy it is imperative U.S. companies maintain a competitive advantage by understanding industry developments across global markets. The most successful companies embrace internati ...Breakout Session
-
Business Development and Investment
-
-
Company Presentation
Ynno Med is a drug R&D company committed to addressing the unmet clinical needs for new antimicrobial agents to combat antimicrobial resistance. Our goal is to design, develop, and distribute first-in ...Company Presentation-
Infectious Disease and Vaccines
-
-
Extended reality (XR) sensory technologies enhance patient agency. This multi-purpose tool elevates patient education, provider communication, multi-dimensional therapy, and comprehensive assessments. ...Special Program
-
AI and Digital Health
-
-
Angea Therapeutics is advancing a gene therapy platform for the treatment of cardiovascular disorders, including ACTA2-mediated Multisystemic Smooth Muscle Dysfunction Syndrome (MSMDS) and Generalized ...Start-Up Stadium
-
Cell and Gene Therapy and Genome Editing
Speakers -
-
The evolving regulatory landscape is opening new doors for biopharma companies to bring therapies to market faster and more efficiently. Programs like the FDA’s Advanced Manufacturing Platform (AMT), ...Breakout Session
-
Emerging Opportunities in Global Markets
Sponsored by:
Speakers -
-
Company Presentation
GENIXCURE develops next generation AAV capsids through its proprietary AI system, InsightMiner and it also develops AAV gene therapy programs to cure ALS, SMA, Alzheimer's disease and Lafora disease. ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Cancer care is at a pivotal moment. Breakthroughs in precision medicine, immunotherapy, artificial intelligence and data-driven diagnostics are transforming how we detect, treat and manage cancer. Yet ...Breakout Session
-
Oncology
Sponsored by:
Speakers -
-
Company Presentation
Seal Rock Therapeutics is developing small molecule kinase inhibitors in the groundbreaking LRRK2/ASK1 Signaling Complex (LASC) inhibitor class of disease-modifying therapies for Parkinson’s disease a ...Company Presentation-
Brain Health
Primary Speaker -
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
3:10 PM (ET)
-
Canal Therapeutics is a new startup to develop novel analgesics through precise regulation of ion channels. Backed by both human genetics and animal model data, the strategy of harnessing ion channel ...Start-Up Stadium
-
Cell and Gene Therapy and Genome Editing
Speakers -
3:15 PM (ET)
-
Company Presentation
.png)
Phycoil Biotechnology International Inc., based in Fremont, California, is an innovative biotech company leveraging a proprietary microbial platform to develop sustainable, plant-based bio-products. W ...Company Presentation-
Brain Health
-
-
Company Presentation
Axcynsis Therapeutics is a multi-platform antibody-drug conjugate (ADC) development company focused on creating next-generation ADC therapies incorporating a proprietary payload, AxcynDOT, designed to ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
Mind Pharmaceuticals Corp, New Haven,CT is a clinical stage biotechnology company in the psychiatry and CNS psychedelic space. We are leveraging Yale University intellectual property, and clinical tri ...Company Presentation-
Brain Health
Primary Speaker -
-
Company Presentation
ProBio is a global leader in advancing the development and manufacturing of next generation biologics and advanced therapies for the biotech and pharmaceutical industries. As a fully integrated end-to ...Company Presentation- Contract Manufacturing Organization
Primary Speaker
3:20 PM (ET)
-
Start-Up Stadium-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
3:30 PM (ET)
-
Company Presentation
At Oxford BioTherapeutics, our oncology discovery capabilities span a diverse range of modalities, all underpinned by our proprietary target discovery platform OGAP®-Verify that drives our mission to ...Company Presentation-
Oncology
-
-
Company Presentation
We are an advanced preclinical biotech developing a high affinity humanized antibody targeting vascular disorders related to VEGF signaling. Edema is a contributor to poor outcomes in a number of dise ...Company Presentation-
Brain Health
-
-
EyeVision Pharma (EP) is using artificial intelligence drug combination platform to develop ocular restricted eyedrops to inhibit the axial elongation of the eye, underlying cause of myopia. Myopic vi ...Start-Up Stadium
- Ophthalmology
-
Company Presentation
Shield Therapeutics is a commercial stage specialty pharmaceutical company with a focus on addressing iron deficiency with its lead medicine ACCRUFeR®, a novel, stable, non-salt based oral therapy for ...Company Presentation- Multiple Therapeutics
Primary Speaker -
Company Presentation
Mirai Bio Inc. is revolutionizing the field of genetic medicine by serving as a comprehensive solutions provider for genetic medicine development, focusing on ML-enabled nucleic acid design, delivery, ...Company Presentation- Platform for Therapeutics
Primary Speaker
.jpg)
.jpg)
3:45 PM (ET)
-
Company Presentation
Osmol is a clinical stage biopharma company advancing technology licensed from Yale to develop a first-in-class preventative treatment for chemotherapy-induced peripheral neuropathy (CIPN). CIPN is a ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
NanoSyrinx is an award-winning, discovery stage biotechnology company based in the UK. We are using synthetic biology approaches to develop protein Nanosyringes as a next-generation platform technolog ...Company Presentation- Platform for Therapeutics
Primary Speaker -
Company Presentation
King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) is a premier institution in the Kingdom of Saudi Arabia specializing in health sciences education and research. Established in collabor ...Company Presentation- Other
-
Company Presentation
Merz Therapeutics is a specialty neurology biopharma focused on movement disorders, rare and ophan neurological diseases and chronic pain seeking in-licensing and acquisition opportunities. Areas of h ...Company Presentation-
Brain Health
-
4:00 PM (ET)
-
Company Presentation
.png)
Creating the ideal immunotherapy which provides potent tumour-selective delivery and tumour-selective killing ability through IV delivery. Lead program entering the clinic in 2025.Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
Pin Therapeutics was founded in South Korea in 2018. We are an innovative biotech company developing a targeted protein degradation platform focused on novel E3 ligases (PinE3) and molecular glue degr ...Company Presentation- Platform for Therapeutics
Primary Speaker -
Company Presentation
-
Company Presentation
CervoMed is a clinical-stage company that is a leader in developing a disease modifying treatment for dementia with Lewy bodies (DLB), the 3rd most common chronic neurodegenerative disorder, trailing ...Company Presentation-
Brain Health
Primary Speaker -
.jpg)
4:15 PM (ET)
-
In 1901, the first Nobel Prize was awarded to recognize those who “have conferred the greatest benefit to humankind.” Often the work that goes into winning this prestigious award occurs over decades a ...Breakout Session
-
Translational Research
-
-
The rapid advancement of DNA foundation models is transforming our ability to decode complex genomic patterns and regulatory mechanisms. This session will explore the current state of these models, th ...Breakout Session
-
AI and Digital Health
Speakers -
-
This session will explore the priority review voucher (PRV) program as proposed in a 2006 paper by Ridley, Grabowski, and Moe and became law in 2007. The PRV allowed the FDA to encourage R&D in neglec ...Breakout Session
-
Business Development and Investment
Speakers -
-
This past year has seen many early-stage deals involving platform technologies ranging from AI drug discovery to building blocks for gene therapy products. In this panel, speakers will explore platfor ...Breakout Session
-
Business Development and Investment
ModeratorSpeakers -
-
There is much to be said for the humanitarian impulse to expand access to life-saving medicines in resource challenged geographies, but the realities on the ground tell us that the humanitarian impuls ...Breakout Session
-
Emerging Opportunities in Global Markets
ModeratorSpeakers -
-
The session explores novel technologies and public-private partnerships that can end deaths from influenza in our lifetime. Last flu season saw illnesses, medical visits, hospitalizations, and deaths ...Breakout Session
-
Infectious Disease and Vaccines
Moderator -
-
As biological threats evolve, traditional stockpiling strategies need to adapt to ensure both readiness and flexibility. This session will delve into dual-use models that serve commercial and public h ...Breakout Session
-
Business Development and Investment
Speakers -
-
Getting a foothold in the biotech industry isn’t easy. If you have a game-changing biotech idea that will make a difference for cancer patients, you’ll need funding and entrepreneurship expertise to t ...Breakout Session
-
Oncology
Speakers -
-
As it has touched so many different areas of human activity, so has artificial intelligence (AI) touched biotechnology and, by extension, biotechnology intellectual property. Panelists will discuss th ...Breakout Session
-
Intellectual Property and Legal Landscape
Moderator -
-
In a recent survey, overall partner ratings by large pharma customers were much higher in comparison to ratings given by smaller biotechs, displaying a potential disparity in how partner organizations ...Breakout Session
-
Biomanufacturing
Speakers -
-
As the search for effective treatments for Alzheimer’s disease intensifies, join us for a compelling panel discussion on the next-generation therapies reshaping the landscape of this devastating condi ...Breakout Session
-
Brain Health
-
-
Following her fireside chat, join Dava Sobel for a book signing and meet and greet. Complimentary copies of the books will be available at the signing on a first come, first served basis. Book signing ...Special Program
-
Special Program
-
-
Extended reality (XR) sensory technologies enhance patient agency. This multi-purpose tool elevates patient education, provider communication, multi-dimensional therapy, and comprehensive assessments. ...Special Program
-
AI and Digital Health
-
-
For too long, women’s health has been overlooked, in research, in funding, and in the way we understand disease. But the science is clear: understanding sex differences doesn’t just improve health out ...Special Program
-
Special Program
-
-
Hear from Advanced Research Projects Agency for Health (ARPA-H) leadership and agency program and project performers as they discuss the agency’s efficient and unique model to fund health-related rese ...Breakout Session
-
Business Development and Investment
Speakers -
-
Company Presentation
Ananda is a clinical-stage biotech developing immunotherapies to reverse autoimmunity, harnessing regulatory T cells (Tregs) to restore immune tolerance and a healthy balance to the immune system. Ana ...Company Presentation- Immunology
Primary Speaker -
Company Presentation
Alligator is a clinical-stage biotechnology company developing tumor-directed immuno-oncology antibody drugs focused on the CD40 receptor. This validated approach promotes priming of tumor-specific T ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
immunitoAI is an India-based TechBio company developing AI-generated novel antibody therapeutics with high efficiency, ensuring successful antibody drug generation even for difficult and undruggable t ...Company Presentation- Platform for Therapeutics
Primary Speaker
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
4:30 PM (ET)
-
Company Presentation
ImmuneWalk Therapeutics is clinical-Stage company developing therapies for I&I. Our main program is based on the discovery of a novel adhesion checkpoint, that controls the ability of certain immune c ...Company Presentation- Immunology
Primary Speaker -
Company Presentation
Silver Creek Pharmaceuticals combines the natural and validated therapeutic power of growth factors with molecular engineering to develop differentiated medicines for critical patient needs. We aim to ...Company Presentation-
Brain Health
Primary Speaker -
-
Company Presentation
NBPI is a unique and differentiated biopharmaceutical company that operates at the forefront of nucleic acid drug delivery technologies. In driving Nitto’s corporate vision of Innovation for Customers ...Company Presentation- Platform for Therapeutics
-
Company Presentation
Fovero Therapeutics is a pre-clinical biotech developing novel immunotherapies for cancer and autoimmune diseases. Our lead program, FT002, is a best-in-class antibody targeting Galectin-9, with a mec ...Company Presentation-
Oncology
-
.jpg)
4:45 PM (ET)
-
Company Presentation
Azafaros, founded in 2018, is a clinical-stage company addressing lysosomal storage disorders, including GM1 and GM2 gangliosidoses and Niemann-Pick type C. With roots in discoveries from Leiden Unive ...Company Presentation-
Brain Health
Primary Speaker -
-
Company Presentation
CHA Vaccine Institute (KOSDAQ: 261780) – Pioneering Next-Generation Vaccines & Immunotherapies CHA Vaccine Institute is a cutting-edge biotechnology company dedicated to developing transformative ther ...Company Presentation- Immunology
-
Company Presentation
Infensa Bioscience: Pioneering Cardioprotection and Neuroprotection Through ASIC1a Inhibition Infensa Bioscience is a private biotech company advancing IB409, a potent ASIC1a inhibitor targeting cardi ...Company Presentation- Cardiovascular
Primary Speaker -
Company Presentation
VerImmune is harnessing the natural geometric structure of viruses to create a self-assembling Virus-inspired Particle (ViP™) platform for targeted therapeutic delivery of diverse payloads for oncolog ...Company Presentation- Platform for Therapeutics
Primary Speaker
.jpg)
.jpg)
5:00 PM (ET)
-
Company Presentation
Tonix is a fully integrated biopharmaceutical company focused on transforming therapies for pain management and vaccines for public health challenges. Tonix’s development portfolio is focused on centr ...Company Presentation-
Brain Health
-
-
Company Presentation
ILIAS Biologics Inc. is a clinical-stage biotech company specializing in exosome-based therapeutics. Our proprietary platform is designed to deliver a wide range of therapeutic modalities that target ...Company Presentation- Platform for Therapeutics
-
Company Presentation
.jpg)
DatChem developed technology for magnetic resonance two-dimensional COrrelated SpectroscopY protocol that records the chemical state of human tissue in vivo in a clinical scanner. The technology has d ...Company Presentation- Medical Devices
Primary Speaker -
Company Presentation
Novelty Nobility is a clinical stage biotechnology company developing fit-for-purpose antibodies to deliver meaningful therapeutic benefits to patients. Starting with the end in mind, the Company is c ...Company Presentation- Immunology
Primary Speaker
5:15 PM (ET)
-
Company Presentation
CentricsBio is a biotech venture company established in 2017 and located at South Korea. This company is developing mAb against CD300c on Monocyte. Once this mAb binds into CD300c on Monocyte, the Mon ...Company Presentation- Immunology
-
Company Presentation
Gelomics is an Australian deep-tech biotechnology company revolutionising drug development by replacing animal testing with human-relevant 3D cell culture technologies. Headquartered in Brisbane, Gelo ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
Ignis Therapeutics, founded in 2020 and headquartered in Shanghai, China, is a pioneering biopharmaceutical company dedicated to advancing innovative therapies for central nervous system (CNS) disorde ...Company Presentation-
Brain Health
Primary Speaker -
-
Company Presentation
InSphero is the pioneer of scalable, reliable, and reproducible 3D cell-based assay solutions for drug safety and efficacy testing. With its efficient automation- and AI-compatible platforms, InSphero ...Company Presentation- Contract Research Organization
Primary Speaker
9:00 AM (ET)
-
Please see the important note below about bags not being allowed in this session. We’re honored to host special guest George W. Bush, 43rd President of the United States and Founder of the George W. B ...Featured Program
-
Special Program
-
.jpg)
10:30 AM (ET)
-
Company Presentation
At Avanzanite Bioscience, we see vast untapped potential in healthcare, particularly for underserved patient populations and overlooked European markets. Our mission is to unlock this potential by bri ...Company Presentation-
Orphan and Rare Disease
-
-
Company Presentation SessionCompany Presentation Session
-
Business Development and Investment
Thank you to our Company Presentation sponsors:
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.Loading
-
-
The Netherlands: Europe's connected Life Sciences & Health Metropolis. Life Sciences businesses in the Netherlands profit from countless opportunities for growth and collaboration. The highly collabor ...Global Innovation Hub 152 -
Company Presentation
Dr. Reddy's Laboratories Ltd (Dr. Reddy's), is an integrated global pharmaceutical company serving +800 million patients globally across 76 countries across US, Europe and Emerging markets. Dr. Reddy' ...Company Presentation-
Oncology
-
-
Company Presentation
Consano Bio is developing a first in category, disease modifying Biologic to treat radicular pain. We have submitted our first IND (CBER) for the treatment of chronic Lumbosacral Radiculopathy, a dise ...Company Presentation- Regenerative Medicine
-
BioProcess International TheaterBioProcess International Theater
-
Biomanufacturing
-
-
BioProcess Session
-
Biomanufacturing
-
-
Company Presentation
LinqMed Inc. is a Japan-based radiopharmaceutical start-up and a pioneering the development of “Visible Cancer Therapeutics” that combine diagnosis and therapy in a single platform using the copper ra ...Company Presentation-
Oncology
Primary Speaker -
10:45 AM (ET)
-
Company Presentation
Established in 2024, ODDIFACT is a ‘‘TechDev’’ AI native company specialized in the repositioning of biologics for rare diseases through the submission of Orphan Drug Designation, turning off-label us ...Company Presentation-
Orphan and Rare Disease
-
-
Company Presentation
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived ma ...Company Presentation- Regenerative Medicine
-
The EIC serves as the European Union's premier programme to identify, develop, and scale up breakthrough technologies and innovations. With a budget of €10 billion for 2021-2027, the EIC aims to posi ...Global Innovation Hub 152 -
This presentation will provide the attendee with a specific overview that will cover how the current pharma landscape utilizes best practices to address the many evolving challenges of supply chain in ...BioProcess Session
-
Biomanufacturing
-
-
Company Presentation
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune ...Company Presentation-
Oncology
-
-
Company Presentation
Cyrus Therapeutics Inc. is a clinical trial-ready stage biotechnology company focused on discovering and developing innovative medicines to address chronic or life-threatening diseases with significan ...Company Presentation-
Oncology
Primary Speaker -
.jpg)
11:00 AM (ET)
-
The US life science industry and ecosystem have been an unparalleled engine for transformative medical innovation since the passage of the Bayh-Dole Act in 1980. Since then and through 2022, fueled by ...Breakout Session
-
AI and Digital Health
ModeratorSpeakers -
-
“Insanity is doing the same things over and over but expecting different results,” Rita Mae Brown. Most of us would agree. And yet, year after year, we invest over $90 billion in R&D, only to face a s ...Breakout Session
-
Oncology
ModeratorSpeakers -
-
In recent years, public health advocacy has played an increasingly critical role in shaping legislation and policy decisions regarding vaccines. Shifting political landscapes, public opinion, and misi ...Breakout Session
-
Infectious Disease and Vaccines
-
-
From R&D, regulatory approval pathways to considerations for launching cell and gene therapies, this session is intended to shed a light on European and Middle Eastern (focus on Saudi Arabia and UAE) ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
ModeratorSpeakers -
-
As the demand for personalized therapies increases, the ability to efficiently produce living medicines at scale is more critical than ever. This session will explore cutting-edge advancements in biom ...Breakout Session
-
Biomanufacturing
-
-
Developing innovative diagnostic tests that address unmet clinical needs and improve upon standards of care requires a significant investment of time and resources. Precision medicine companies willin ...Breakout Session
-
Diagnostics and Personalized Medicine
-
-
How do venture capitalists evaluate early stage life science companies to decide where to place their bets? Learn how high-profile VCs evaluate startups, and what data sets are most important for earl ...Breakout Session
-
Business Development and Investment
-
-
Women on social media sites (TikTok) have been speaking out about IUD pain, with some describing the procedure as “the worst pain imaginable” or saying they “almost passed out.” Duke University resear ...Breakout Session
-
Regulatory Innovation
Speakers -
-
Fireside ChatWhat does it take to create a new medicine? The trajectory from laboratory to your neighborhood chemist rarely runs in a straight line. Eureka moments come few and far between. Drug discoveries demand ...Fireside Chat
-
Business Development and Investment
-
-
Public-private partnerships and supportive state legislative measures aimed at growing biomanufacturing capacity in the United States are providing significant economic on-shoring value, and are essen ...Special Program
-
Biomanufacturing
Speakers -
-
The Storytelling Stage is accessible to all registered attendees. You can find it located in the Exhibition Hall - Booth #349. The BIO Storytelling Stage is a showcase of the heart of BIO's priorities ...Storytelling Stage Storytelling Stage (Booth #349)
-
Company Presentation
Immunis is a clinical-stage biotech developing multi-active biologics to address age-related diseases and immune dysregulation. Metabolic and immune health decline with age, commonly manifesting as mu ...Company Presentation- Regenerative Medicine
Primary Speaker -
Company Presentation
PRG S&Tech is a company specializing in the research and development of treatments for rare genetic diseases. Developing non-marketable treatments for such diseases is inherently challenging, especial ...Company Presentation-
Orphan and Rare Disease
-
-
We will present an update from the Global Innovation Hub Switzerland including general trends in financing, partnering and international collaborations, and opportunities to liaise with the > 1500 Swi ...Global Innovation Hub 152 -
Since the passage of 21st Century Cures, FDA collaboration with the rare disease patient and scientific community has never been greater. The creation of a Rare Disease Innovation Hub also holds promi ...Breakout Session
-
Orphan and Rare Disease
Sponsored by:
-
-
The BIO Storytelling Stage is a showcase of the heart of BIO's priorities—sharing the stories of the biotechnology industry that show who we are, who we serve, what we do, and why we do it. You'll hea ...Storytelling Stage Storytelling Stage (Booth #349)
-
Start-Up Stadium Session
-
Business Development and Investment
-
-
Company Presentation
Henlius (2696.HK) is a global biopharmaceutical company with the vision to offer high-quality, affordable and innovative biologic medicines for patients worldwide with a focus on oncology, autoimmune ...Company Presentation-
Oncology
-
-
As the biotech industry faces growing complexity in regulatory expectations and clinical trial innovation, oncology developers must adopt smarter, more agile strategies to advance their pipelines. Pan ...Breakout Session
-
Oncology
Sponsored by:
-
-
Company Presentation
At Aspeya, we want to make a positive difference to people’s lives. We’re harnessing deep insight and scientific expertise to reimagine how ingredients can be used, and working towards the development ...Company Presentation- Multiline Global Biopharma
Primary Speaker
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
11:10 AM (ET)
-
Binary Genomics is developing a DNA-based blood test for pan-cancer detection and monitoring. Our test captures unique epigenetic fingerprints from each patient’s tumor, regardless of cancer type, inc ...Start-Up Stadium
-
Diagnostics and Personalized Medicine
Speakers -
11:15 AM (ET)
-
Choose Québec, a thriving environment for precision medicine Québec is a major hub for health biotech, fostering precision medicine innovation. Global leaders like Abbott, GSK, Medicago, Merck, Modern ...Global Innovation Hub 152 -
Company Presentation
Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and othe ...Company Presentation-
Oncology
-
-
Company Presentation
national initiative supporting Saudi Arabia’s Vision 2030 healthcare goals. It is one of the largest biobanks in the Kingdom and the first to receive ISO accreditation, ensuring world-class standards. ...Company Presentation- Other
-
Company Presentation
JangoBio is a biotechnology company that develops advanced therapeutics to improve healthy aging in humans and animals. Imagine turning back the hands of time: Running a marathon like you did when you ...Company Presentation- Regenerative Medicine
Primary Speaker -
Company Presentation
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are ...Company Presentation-
Oncology
-
11:20 AM (ET)
-
Start-Up Stadium-
Diagnostics and Personalized Medicine
Primary Speaker -
-
Traditional batch-based biologics manufacturing is limited by sequential processing, high infrastructure costs, and low productivity. Enzene’s Fully-Connected Continuous Manufacturing™ (FCCM™) platfor ...BioProcess Session
-
Biomanufacturing
-
11:30 AM (ET)
-
Company Presentation
Neurizon is a publicly listed Australian company (ASX:NUZ) that is developing NUZ-001 for the treatment of neurodegenerative diseases. NUZ-001 is a small molecule mTOR inhibitor that activates autopha ...Company Presentation-
Orphan and Rare Disease
-
-
Company Presentation
Fapon Biopharma specializes in discovering and developing biologics for treating cancers, autoimmune diseases and other diseases where there are unmet medical needs. Leveraging cutting-edge technologi ...Company Presentation-
Oncology
Primary Speaker -
-
Presentation "Top Reasons to Invest in France" at the GIH - Bio International Convention 2025 - Context: France is a major player in terms of biotech innovation, and the French authorities have set an ...Global Innovation Hub 152 -
Start-Up Stadium-
Diagnostics and Personalized Medicine
Primary Speaker -
-
Company Presentation
TBDCompany Presentation- Multiple Therapeutics
-
Company Presentation
At Animate Biosciences, we’re driven by a vision to outsmart one of the deadliest biological challenges: fibrosis. We have pioneered an innovative approach to amino acid-based therapeutics by integrat ...Company Presentation- Regenerative Medicine
Primary Speaker
11:40 AM (ET)
-
When a catastrophic compliance failure derailed Veloxis’ relationship with its incumbent biologics CDMO, the team faced a critical challenge: find a new partner and recover the CMC timeline ahead of P ...BioProcess Session
-
Biomanufacturing
-
11:45 AM (ET)
-
Company Presentation
GI Innovation, a KOSDAQ-listed biotech, pioneers fusion protein drugs for cancer and allergies. Since 2017, it secured $230 million through funding rounds, IPO, and licensing deals for preclinical and ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
.png)
Caliway Biopharmaceuticals (Caliway) is a clinical-stage biopharmaceutical company driven to breakthrough drug discovery of medical aesthetics and inflammatory of small-molecule therapeutics. In the c ...Company Presentation- Dermatology
Primary Speaker -
Company Presentation
Boehringer Ingelheim is a leading research-driven biopharmaceutical company. Making new and better medicines for patients is at the heart of what we do. As an independent company, we have the freedom ...Company Presentation- Other
-
Start-Up Stadium-
Diagnostics and Personalized Medicine
Primary Speaker -
-
Company Presentation
Hopstem is dedicated to developing allogeneic iPSC cell therapy for global CNS diseases patients. Our first iPSC cell therapy product hNPC01, the forebrain neural progenitor cell injection, received I ...Company Presentation- Regenerative Medicine
Primary Speaker
.jpg)
12:00 PM (ET)
-
Company Presentation
Amgen harnesses the best of biology and technology to fight the world’s toughest diseases, and make people’s lives easier, fuller and longer. We discover, develop, manufacture and deliver innovative m ...Company Presentation- Multiple Therapeutics
-
Company Presentation
SONIRE is a Tokyo-based startup founded in February 2020, developing an ultrasound-guided HIFU therapy system using technology (Code Name: Suizenji) created at Tohoku University. Suizenji delivers foc ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
Azitra is a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology. The Company's lead candidate, ATR-12, is an engineered strain of S. epidermid ...Company Presentation- Dermatology
Primary Speaker -
Sweden stands at the forefront of the global life science industry, renowned for its groundbreaking innovations, cutting-edge research, and dynamic ecosystem of biotech, medtech, and pharmaceutical co ...Global Innovation Hub 152 -
Start-Up Stadium-
Diagnostics and Personalized Medicine
Primary Speaker -
-
Company Presentation
KAER was founded in 2008 and is based in Southern California, USA. KAER produces respiratory aerosol delivery platforms, including AeroPulsR and SUPRAER. These platforms deliver high-concentrations of ...Company Presentation- Respiratory
Primary Speaker
.jpg)
12:10 PM (ET)
-
Start-Up Stadium-
Diagnostics and Personalized Medicine
Primary Speaker -
12:15 PM (ET)
-
Following his fireside chat, join Dr. William Pao for a book signing and meet and greet. Complimentary copies of the books will be available at the signing on a first come, first served basis. Book si ...Special Program
-
Business Development and Investment
-
-
Super SessionBiopharma companies encounter crucial commercial barriers as they navigate their assets from molecule to marketplace. In a contemporary landscape where product types and therapies are diversifying, bi ...Super Session
-
Business Development and Investment
Sponsored by:
-
-
Company Presentation
Servier is an independent pharmaceutical company committed to therapeutic progress to serve patient needs. Its unique governance allows Servier to reinvest all its profits to support its development, ...Company Presentation-
Oncology
Primary Speaker -
-
A full overview of Italy's Biotech ecosystem, outlining the competitiveness and leadership in the European context, the main public incentives benefits and the key investment opportunities.Global Innovation Hub 152 -
Company Presentation
Alphyn’s Zabalafin Drug Platform is unique, impactful and highly important because it contains multiple bioactive compounds that have multiple mechanisms of action to power a new class of drugs called ...Company Presentation- Dermatology
Primary Speaker -
Company Presentation
VSPharmTech (VSPT), a clinical stage biotechnology company, has been dedicated to developing innovative therapeutics to achieve paradigm shift for cancer patients. VSPT, whose leadership team is compo ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing the investigational therapy Haduvio™ (oral nalbuphine extended-release) for the treatment of chronic cough in patients ...Company Presentation- Respiratory
Primary Speaker -
Super SessionJoin as Johnson & Johnson’s Penny Heaton, MD, Global Head of the Johnson & Johnson Office of the Chief Medical Officer, and Nauman Shah, Global Head of Innovative Medicine Business Development, discus ...Super Session 253ABC
Sponsored by:
.jpg)
.jpg)
12:20 PM (ET)
-
Start-Up Stadium-
Infectious Disease and Vaccines
Primary Speaker -
12:30 PM (ET)
-
Start-Up Stadium-
Infectious Disease and Vaccines
Primary Speaker -
1:20 PM (ET)
-
BioProcess Session
-
Biomanufacturing
-
1:30 PM (ET)
-
This film follows two families as they begin a clinical drug trial that seems to offer the best hope for their children. Both families connect with the STXBP1 community for guidance and support on the ...Storytelling Stage Storytelling Stage (Booth #349)
-
Join us to hear from our finalists and discover who will receive over $250,000 in bioprocessing technologies, bioprocessing consulting services, contract testing services. The next round of applicatio ...Start-Up Stadium Session North Lobby
1:40 PM (ET)
-
BioProcess Session
-
Biomanufacturing
-
1:45 PM (ET)
-
This panel will explore the vital role of patients and their families in driving innovation in rare disease therapies. By sharing personal experiences and expert insights, panelists will highlight how ...Breakout Session
-
Orphan and Rare Disease
ModeratorSpeakers -
-
Biotechnology companies are producing remarkable therapies at an unprecedented pace. In the past year, two new gene therapies have come to market for patients suffering from sickle cell disease. Rapid ...Breakout Session
-
Infectious Disease and Vaccines
Speakers -
-
This session will explore how investments and bold bets in accelerated computing, data generation at scale, and model-first strategies are revolutionizing the industry, without ignoring the initial ch ...Breakout Session
-
AI and Digital Health
Speakers -
-
The rapid advancement of cell therapies has opened new frontiers in regenerative medicine, but it has also highlighted significant regulatory hurdles across global jurisdictions. One of the most press ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
Speakers -
-
R&D is often the most cost-intensive and risky step in a new drug's life cycle yet often dictates the speed and adaptability of the innovation ecosystem. The time and capital required for biotech to t ...Breakout Session
-
Business Development and Investment
-
-
The cancer therapeutics landscape is constantly evolving as breakthroughs across modalities drive toward the shared goal of providing accessible and life-saving treatments to patients. Companies are a ...Breakout Session
-
Oncology
-
-
The economics of rare-disease research is a consistent obstacle to progress. Although there are more than 10,000 rare diseases that collectively affect over 30 million people in the United States, eac ...Breakout Session
-
Orphan and Rare Disease
Moderator -
-
Representatives from biotech, academia, patient advocacy, and the investor community will have a robust and interactive discussion about next generation therapies to treat blinding eye diseases that a ...Breakout Session
-
Next Generation Biotherapeutics
-
-
This data-driven session from BIO and its market intelligence partner, Norstella, will dive into the state of play for emerging biotech companies. From venture capital and public financing, deal-makin ...Breakout Session
-
Business Development and Investment
-
-
Fireside ChatJoin us for an exclusive fireside chat with Feng Zhang, PhD, renowned scientist and core member of the Broad Institute, an Investigator at the McGovern Institute for Brain Research, the James and Patr ...Fireside Chat
-
Next Generation Biotherapeutics
-
-
Whether you're just starting your career or looking to take the next big step, this session will help you navigate the biotech industry. We will begin with an overview of what biotechnology is and its ...Student Program 209
-
Super SessionStrategic partnerships between biotech innovators, VCs and pharmaceutical companies have become the cornerstone of drug development, illustrating a beneficial exchange where cutting-edge research meet ...Super Session
-
Business Development and Investment
Sponsored by:
-
-
Fireside ChatSince its founding, Pennsylvania has been a leader in medicine and the life sciences. The first hospital in the United States was established in Philadelphia in 1751 followed by the first school of ph ...Fireside Chat
-
Value‚ Patient Access and Reimbursement
-
-
The presentation will cover the key aspects you need to know about Lithuania - the business environment, current life sciences ecosystem, and why local and foreign investors are choosing to locate in ...Global Innovation Hub 152 -
Company Presentation
Greenwich LifeSciences, (Nasdaq: GLSI) is a clinical-stage biopharmaceutical company focused on a Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breas ...Company Presentation-
Oncology
-
-
Company Presentation
.png)
We are revolutionizing drug delivery by harnessing proprietary progenitor cell nanotechnology to deliver medicines in a better way. We are currently in the midst of IND-enabling studies for IB001 for ...Company Presentation- Platform for Therapeutics
-
Company Presentation
.png)
At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the ...Company Presentation- Multiline Global Biopharma
-
Real-world data (RWD) has long informed clinical research, but traditional sources - electronic health records, claims data, registries - often provide only a partial view of patient health. This can ...Breakout Session
-
Diagnostics and Personalized Medicine
Sponsored by:
-
-
Company Presentation
Xzōm – Early Enough. Xzōm is pioneering the future of early disease detection through its proprietary liquid biopsy platform, which leverages on-chip exosome analysis to deliver clinical-grade diagnos ...Company Presentation-
Diagnostics and Personalized Medicine
Primary Speaker -
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
1:50 PM (ET)
-
BioProcess Session
-
Biomanufacturing
-
2:00 PM (ET)
-
Company Presentation
BioAro Inc., a Calgary-based Canadian biotechnology leader, is revolutionizing precision medicine through innovative solutions in Point-of-Care (POC) In Vitro Diagnostics (IVD), wearable sensors, and ...Company Presentation-
Diagnostics and Personalized Medicine
Primary Speaker -
-
Company PresentationAilux Biologics is the biologics division of XtalPi (“XtalPi Holdings Limited”, stock code: 2228.HK), a global leader in AI-driven drug discovery. At Ailux, we are dedicated to developing differentiat ...Company Presentation
- Platform for Therapeutics
-
Belgium is a European frontrunner in life sciences, biotech, medtech, and healthtech. With a dense network of innovative companies, top-tier research institutions, and strong government support, the c ...Global Innovation Hub 152
-
Company Presentation
Cytovation is a biotechnology company pioneering a novel class of bifunctional peptide therapeutics that target tumors with immune-excluded microenvironments. Its lead candidate, CY-101, is a syntheti ...Company Presentation-
Oncology
Primary Speaker -
-
Start-Up Stadium Session
-
Business Development and Investment
-
-
There are many factors to consider when selecting a chromatography resin for use in a biopharmaceutical purification process. No longer does a singular affinity solution address the needs of increasin ...BioProcess Session
-
Biomanufacturing
-
-
Company Presentation
Sanofi is an innovative global healthcare company, driven by one purpose: to chase the miracles of science to improve people's lives. Their team, across approximately 100 countries, is dedicated to tr ...Company Presentation- Multiple Therapeutics
Primary Speaker -
BioProcess International TheaterBioProcess International Theater
-
Biomanufacturing
-
2:10 PM (ET)
-
Start-Up Stadium- Inflammation
Primary Speaker
2:15 PM (ET)
-
Company Presentation
SLAM Bio is an oncology biotech company developing a platform of first-in-class antibodies and ADCs against signaling lymphocytic activation molecule (SLAM) protein family. This is an intriguing biote ...Company Presentation-
Oncology
Primary Speaker -
-
.jpg)
Brisbane and Queensland are at the forefront of a life sciences revolution, emerging as a global destination within Australia ripe for investment and expansion. With the health sector projected to gro ...Global Innovation Hub 152 -
Company Presentation
Foli Bio is pioneering a next-generation transcriptomics and immune profiling platform to advance drug development and precision medicine. We have discovered that exfoliated biological material, such ...Company Presentation- Platform for Therapeutics
-
Company Presentation
Phenomics Health™ is the first precision medicine company to personalize drug treatment by predicting the optimal medication and dose for each patient. We combine drug level measurement with tools to ...Company Presentation-
AI and Digital Health
Primary Speaker -
-
Company Presentation
At Merck, known as MSD outside of the United States and Canada, we are unified around our purpose: We use the power of leading-edge science to save and improve lives around the world. For more than 13 ...Company Presentation- Multiple Therapeutics
2:20 PM (ET)
-
Start-Up Stadium- Metabolic Diseases
Primary Speaker
2:30 PM (ET)
-
Company Presentation
Chugai, a member of Roche group, is a Japanese company focused on creating innovative medicinal products which address unmet medical needs. Our innovative antibody technologies have led to multiple th ...Company Presentation- Multiline Global Biopharma
-
Company Presentation
-
Highlighting Japan as an attractive market for investments and collaboration in life sciences.Global Innovation Hub 152
-
Company Presentation
Avidicure is a privately held biotechnology company that has developed an entirely new multifunctional antibody modality, "AVC-Boosters", delivering targeted and potent immune-modulating therapy for p ...Company Presentation-
Oncology
-
-
Start-Up Stadium- Metabolic Diseases
Primary Speaker -
Company Presentation
.png)
MEDINA is a cutting-edge research organization dedicated to natural product-based drug discovery, with a sharp focus on cancer, neurodegenerative disorders, and infectious diseases. Backed by a strong ...Company Presentation-
AI and Digital Health
-
.jpg)
.jpg)
2:40 PM (ET)
-
Nephrogen is a preclinical biotech spin-out from Stanford University developing curative gene therapies for kidney and pancreatic diseases.Start-Up Stadium
- Metabolic Diseases
Speakers -
Successfully designing and developing next-generation modalities, like antibody-oligonucleotide conjugates (AOCs) and bi/multi-specific antibodies, is a complex, multi-stage process. These innovative ...BioProcess Session
-
Biomanufacturing
-
.jpg)
2:45 PM (ET)
-
Company Presentation
Medincell is a commercial-stage biopharmaceutical licensing company developing long-acting injectable drugs in many therapeutic areas. Our innovative treatments aim to guarantee compliance with medica ...Company Presentation- Platform for Therapeutics
Primary Speaker -
Company Presentation
Samjin Pharmaceutical Co., Ltd., a leading pharmaceutical company in Korea established in 1968, is dedicated to pioneering advancements in therapeutic innovation. Our portfolio features renowned produ ...Company Presentation- Immunology
-
Company Presentation
GenSci is a leading pharmaceutical company in China, with annual sales exceeding $1.5 billion USD in 2023. Building on its core strengths in pediatric and women's health, GenSci has strategically expa ...Company Presentation- Multiline Global Biopharma
Primary Speaker -
Company Presentation
Clinical Stage company focused on Radiopharmaceutical Therapies and ImagingCompany Presentation-
Oncology
-
.jpg)
2:50 PM (ET)
-
.png)
Start-Up Stadium- Metabolic Diseases
Primary Speaker
3:00 PM (ET)
-
Initially drafted in January 2023 and finalized in August 2024, the US Food and Drug Administration (FDA) released guidance tied to Project Optimus, titled “Optimizing the Dosage of Human Prescription ...Breakout Session
-
Oncology
-
-
Recent Nobel Prizes in deep learning, structure prediction, microRNA, and mRNA signal that the pharmaceutical industry is entering a new era of innovation, driven by the rapid rise of generative and f ...Breakout Session
-
AI and Digital Health
Speakers -
-
Originally pioneered as lifesaving treatments for patients with cancer, cell therapies have burst onto the biotech scene as promising, disease-eliminating treatments for autoimmune disorders – a notor ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
-
-
The legal challenges to the Inflation Reduction Act are now mature. It is critical to assess, at this inflection point, what they have and have not accomplished. As cases move from the District Courts ...Breakout Session
-
Intellectual Property and Legal Landscape
-
-
Nearly a quarter of adults in the United States report difficulty affording prescription drugs which is often attributed to the drug’s price set by the manufacturer rather than to the patient out-of-p ...Breakout Session
-
Value‚ Patient Access and Reimbursement
Moderator -
-
This panel will explore the opportunities and hurdles in the dynamic field of advanced biologics manufacturing, where innovative technologies intersect with medical advancements. This domain offers si ...Breakout Session
-
Biomanufacturing
Speakers -
-
Company Presentation
At GenEdit, our mission is to develop innovative genetic medicines with targeted in vivo delivery. Our NanoGalaxy® platform of non-viral, non-lipid hydrophilic nanoparticles (HNPs) offer a combination ...Company Presentation- Platform for Therapeutics
-
Partnering with innovative companies at all stages of development is core to how we discover and develop new groundbreaking medicines. Establishing those deep and successful partnerships presents nume ...Breakout Session
-
Business Development and Investment
Sponsored by:
Speakers -
-
Company Presentation
Kernal Bio is VC-backed biotech company pioneering mRNA 2.0 immunotherapies. We leverage selective mRNA-LNP technology to treat cancer and autoimmune diseases with precision, ensuring targeted deliver ...Company Presentation- Immunology
-
The completion of two seasons of RSV immunization for infants provides us with an opportunity to reflect on ways to enhance policies, programs, and systems to maximize protection for infants. Successf ...Breakout Session
-
Infectious Disease and Vaccines
Sponsored by:
-
-
One Shot to Live - Single-gene therapy may be the greatest hope for thousands of children with rare diseases. But the greatest challenge is time, or the lack of it. The parents of these children fight ...Storytelling Stage Storytelling Stage (Booth #349)
-
Start-Up Stadium-
Oncology
Primary Speaker -
-
Revolutionary breakthroughs in genetic science have transformed what was once a futuristic approach into an attainable shift in the medical paradigm. Today’s tools enable diagnosis and individualized ...Breakout Session
-
Next Generation Biotherapeutics
Speakers -
-
Company Presentation
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of infectious disease and treatment of cancer. We take a unique pan-antigenic approach for our cancer v ...Company Presentation-
Oncology
Primary Speaker -
-
BioProcess Session
-
Biomanufacturing
-
-
Biotechnology is reshaping economies and healthcare systems across the globe, and governments are investing heavily to build national capabilities. Yet at the same time, shifting trade dynamics and ev ...Breakout Session
-
Emerging Opportunities in Global Markets
Speakers -
-
Dr. Martin Adel Makary, was confirmed on March 25, 2025 by the U.S. Senate as the 27th Commissioner of Food and Drugs. In this role, Dr. Makary oversees the full breadth of the FDA portfolio and execu ...Featured Program Main Stage
-
Company Presentation
Clarity is the first FDA authorized prediction tool for breast cancer risk in the next five years. Founded by Dr. Connie Lehman had a breast imaging at a Mass General Hospital and professor of radiolo ...Company Presentation-
AI and Digital Health
Primary Speaker -
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
3:10 PM (ET)
-
Start-Up Stadium-
Oncology
Primary Speaker -
3:15 PM (ET)
-
Company Presentation
ImmuneOnco is a HK-listed (HK.1541), clinical stage biotech company focused on discovering and developing immunotherapies to treat cancer, immune diseases and other diseases. Amulirafusp alfa (IMM0306 ...Company Presentation- Immunology
-
Taiwan has targeted advanced therapy and digital health as its key elements for biomedical industry development. Besides a well-established infrastructure and biomedical clusters, the government has l ...Global Innovation Hub 152 -
Company Presentation
.png)
APITBIO is an innovative biotech venture focused on antibody-based drug discovery, developing a pipeline of first-in-class monoclonal antibodies (mAbs), bispecific antibodies (BsAbs), and antibody-dru ...Company Presentation- Platform for Therapeutics
Primary Speaker -
Company Presentation
Medicus Pharma Ltd. (NASDAQ: MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutics assets. Our lead asset, SkinJect In ...Company Presentation-
Oncology
Primary Speaker -
3:20 PM (ET)
-
Start-Up Stadium-
Oncology
Primary Speaker -
3:30 PM (ET)
-
Company Presentation
Ziphius, a Belgium/US-based private biotech company, is advancing a next-generation platform utilizing self-amplifying RNA (saRNA) and lipid nanoparticles (LNPs) to develop first and best in class med ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Mexico City is a bursting hub for education, innovation and research. This presentation will underline the benefits of partnering with Mexico City to develop more and better research and solutions, wi ...Global Innovation Hub 152 -
Company Presentation
Alivexis, Inc. is a computation-driven drug discovery firm with offices in both Japan and the US. By combining our proprietary cutting-edge computational technology with our deep insights in disease b ...Company Presentation- Multiple Therapeutics
-
Start-Up Stadium-
Oncology
Primary Speaker -
-
Company Presentation
Nanobiotix is a late-stage clinical biotechnology company pioneering disruptive, physics-based therapeutic approaches to revolutionize treatment outcomes for millions of patients; supported by people ...Company Presentation- Platform for Therapeutics
Primary Speaker -
Company Presentation
Isomorphic Labs was founded in 2021, with a mission to transform drug discovery with the power of artificial intelligence. Led by AI pioneer Sir Demis Hassabis, our founding was built on the Nobel-win ...Company Presentation-
AI and Digital Health
Primary Speaker -
.png)
.jpg)
3:40 PM (ET)
-
.jpg)
Start-Up Stadium-
Oncology
Primary Speaker -
3:45 PM (ET)
-
Company Presentation
iosBio is developing a first-in-class Epstein-Barr virus (EBV) vaccine with the potential to revolutionize EBV prevention. Unlike current vaccine candidates that use intramuscular injection and aim to ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Innovating Together for tomorrow health! Welcome to the Occitanie Region, South of France, a center of excellence in health and biotherapies, where history, innovation, and cutting-edge research come ...Global Innovation Hub 152 -
Company Presentation
Asahi Kasei is strengthening its global presence in the pharmaceutical sector through strategic acquisitions and investments. In 2020, Asahi Kasei acquired Veloxis, a US company focusing on solid orga ...Company Presentation- Immunology
-
Company Presentation
Hengrui is the leading research and development company in China, with more than 147 drugs in developmentCompany Presentation- Other
-
Company Presentation
Biomy, Inc. is a Japanese company that developed DeepPathFinder™, a unique AI/DL-automated digital pathology algorithm that can detect, identify, and quantify immune cells in tumor and tumor micro-env ...Company Presentation-
AI and Digital Health
Primary Speaker -
.jpg)
4:00 PM (ET)
-
Company Presentation
UI Pharmaceuticals stands as the longest-running, FDA-registered, university-affiliated pharmaceutical manufacturing facility in the United States. Since 1974, we have been a reliable partner in pharm ...Company Presentation- Contract Manufacturing Organization
-
The biotech industry is at the forefront of groundbreaking innovations, yet securing funding has become increasingly difficult in today’s volatile environment. Market fluctuations, evolving investor e ...BioProcess Session
-
Biomanufacturing
Speakers -
-
: New Zealand’s biotech industry is thriving, driven by cutting-edge research, innovative companies, and a strong bioeconomy. With expertise spanning human and animal health, food, agriculture, and en ...Global Innovation Hub 152Primary Speaker -
Company Presentation
Eradivir is a privately held, clinical-stage biotechnology company focused on the power of the immune system to target and treat viral infections and other diseases. Its proprietary BAiT platform (Bis ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
.jpg)
The Department of Health – Abu Dhabi (DoH) is the regulatory authority for the healthcare sector in the Emirate of Abu Dhabi. It is responsible for ensuring that healthcare provision is of the highest ...Company Presentation-
AI and Digital Health
Primary Speaker -
-
Company Presentation
Lmito, a JLABS Korea portfolio company, is an innovation-driven biotechnology company dedicated to developing novel and effective therapies for autoimmune/ neuroinflammatory diseases and fibrosis thro ...Company Presentation- Immunology
Primary Speaker
.jpg)
.jpg)
4:15 PM (ET)
-
According to the most recently available figures, more than 2,000 new oncology clinical trials have begun since 2023, demonstrating the continued need for innovative and effective cancer therapies. Wh ...Breakout Session
-
Oncology
Speakers -
-
The commitment to women’s health has been increasing over the past year from the US government and dedicated early-stage seed funds. As this funding is deployed to promote innovation and provide solut ...Breakout Session
-
Business Development and Investment
-
-
Intellectual property rights are the bedrock of life-science innovation. But attacks on numerous fronts, from pervasive anti-patent myths to attempts to misuse march-in rights, now threaten to erode t ...Breakout Session
-
Intellectual Property and Legal Landscape
-
-
Co-discovery and co-development partnerships have become a cornerstone of the biopharma industry. These partnerships can unlock the potential for groundbreaking medicines, yet their scientific complex ...Breakout Session
-
Business Development and Investment
Speakers -
-
Why are so many drug discoveries still failing to make it out of the lab when the speed of, and competition for, innovation has never been higher? Could solving this challenge lie in the unique relati ...Breakout Session
-
Translational Research
Speakers -
-
We are witnessing a revolution in rare disease drug development. Traditional models fall short due to small patient populations and limited disease understanding. However, regulatory agencies are now ...Breakout Session
-
Orphan and Rare Disease
-
-
Biopharma’s ability to create new drugs has depended, from the start, on our collective knowledge of Earth’s genetic biodiversity. While many existing datasets have sought to describe the world, they ...Breakout Session
-
AI and Digital Health
-
-
A steady and impressive track record of growth in the life sciences industry has kept access to a skilled, diverse workforce at top of mind for life science leaders, even amid occasional retractions. ...Breakout Session
- Diversity and Opportunity
Speakers -
As gene editing and epigenetics evolve, they are not only transforming how we approach complex diseases but also unlocking new possibilities for enhancing longevity, healthspan, and even organ transpl ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
-
-
Super SessionThis session will open with an overview of Vision 2030 and explanation of the Kingdom’s commitment to the role of biotech in advancing healthcare. A panel discussion will then explore the key drivers ...Super Session 253ABC
Sponsored by:
Speakers -
Company Presentation
Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a gene therapy contract development and manufacturing organization (CDMO) enabling access to life-changing gene therapies by bringing the ...Company Presentation- Contract Manufacturing Organization
-
Company Presentation
Vaxxas' HD-MAP technology uses a patch with thousands of vaccine-coated microprojections that is applied to the skin via an applicator device, for seconds to efficiently deliver vaccine to the abundan ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
Amyl Tx develops innovative biological therapies for the treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s and of systemic amyloidosis. The pathogenesis of several neurodegen ...Company Presentation-
Brain Health
Primary Speaker -
-
BIRAC’s aim is to play a transformative and catalytic role in building a US$ 300 billion Indian bioeconomy. As agents of change for building the India as a global destination for Biotechnology, our fo ...Global Innovation Hub 152 -
Storytelling is a powerful way to connect, and a critical skill for leaders and advocates today. The Moth is an acclaimed nonprofit organization dedicated to the art and craft of true, personal storyt ...Special Program
-
Special Program
-
-
Company Presentation
Ordaos Bio stands at the forefront of intelligent drug design, employing a sophisticated AI engine comprising hundreds of specialized digital models to conceive and engineer novel mini-proteins and si ...Company Presentation- Immunology
Primary Speaker -
Fireside ChatThe biotechnology sector is evolving rapidly, driven by breakthroughs in science, shifts in policy, and growing demand for resilient healthcare systems. In this fireside chat, EU Health and Animal Wel ...Fireside Chat
-
Emerging Opportunities in Global Markets
-
-
This panel will provide a multidimensional, internal look at how different groups across Novo Nordisk collaborate to expand the options available for improving treatments of obesity and diabetes to he ...Breakout Session
-
Business Development and Investment
Sponsored by:
ModeratorSpeakers -
-
This session explores the cutting-edge trends and strategic decisions transforming the modern biotech industry. Our expert panelists will dive into the most impactful technological innovations in larg ...Breakout Session
-
Biomanufacturing
Sponsored by:
-
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
4:30 PM (ET)
-
Company Presentation
Zambon Biotech SA is a specialized biotech company that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, ...Company Presentation-
Brain Health
-
-
Company Presentation
.jpg)
Curapath is a leading CDMO specializing in innovative drug delivery systems (DDS), with expertise in lipid nanoparticles (LNPs) and polymer nanoparticles (PNPs). Offering comprehensive support from de ...Company Presentation- Contract Manufacturing Organization
Primary Speaker -
Company Presentation
Wintermute Biomedical Inc (WBI) is a antimicrobial development company with a focus on topical agents for the treatment of viruses, multi drug resistant bacteria, and fungus. WBI is currently completi ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Come hear from the UK Government’s Department for Business and Trade and the Association of the British Pharmaceutical Industry about the UK’s world class R&D, why it’s a great place for business and ...Global Innovation Hub
-
Company Presentation
Tiba Biotech develops next generation RNA vaccines and therapeutics, with a focus on infectious diseases, cancer, and inflammation. Our proprietary RNABL platform overcomes the limitations of conventi ...Company Presentation- Immunology
Primary Speaker
.jpg)
4:45 PM (ET)
-
Company Presentation
BASF Bioservices provides contract Protein Discovery, Engineering, Microbial Strain & Process Development, and Data Services to Life Science and Biotech companies.Company Presentation- Contract Research Organization
-
Company Presentation
Actinogen is an ASX-listed company conducting late-stage clinical trials in Alzheimer's disease (AD) for its oral small molecule, Xanamem. Xanamem works by controlling the levels of the "stress hormon ...Company Presentation-
Brain Health
-
-
Company Presentation
Evaxion Biotech A/S is a pioneering TechBio company based on its Artificial Intelligence (AI) platform: AI-Immunology™, which enables precise vaccine target discovery and optimization. The AI-Immunolo ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
DPBIO is a pioneering innovator based in California, specializing in high-throughput droplet microfluidic technology and providing cutting-edge life science solutions to researchers and industry leade ...Company Presentation- Tools/Drug Development Support Tech
9:00 AM (ET)
-
Biotech startups emerging from universities are at the forefront of innovation, pushing the boundaries of science and medicine. However, translating groundbreaking research into viable commercial prod ...Breakout Session
-
Translational Research
ModeratorSpeakers -
-
As AI becomes integral to healthcare, ensuring transparency and trust through regulatory compliance is critical. Multi-agent systems, where different AI agents specialize in distinct tasks, are gainin ...Breakout Session
-
AI and Digital Health
Moderator -
-
Back by popular demand, this high-impact session returns to BIO and will guide health and science executives through a proprietary framework developed by LaVoieHealthScience: The LHS Fifteen-Slide Pre ...Breakout Session
-
Business Development and Investment
-
-
The Human Genome Project led to an explosion of knowledge about the genetic roots of disease. Now leaders in genetic medicine technologies, including RNAi therapeutics and CRISPR gene editing, are har ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
Speakers -
-
Biotech is entering a new era of mega blockbusters - drugs with peak sales potential exceeding $10 billion. Drug developers are increasingly focusing on novel therapies that can reach the largest poss ...Breakout Session
-
Business Development and Investment
-
-
The tremendous success of GLP-1/GIP receptor agonists has ushered in a rapid paradigm shift in how we consider and treat chronic metabolic diseases, like obesity and associated comorbidities. These th ...Breakout Session
-
Next Generation Biotherapeutics
Speakers -
-
Join us for a dynamic panel discussion exploring the evolution of investment in medical and healthcare interventions designed to advance health equity. In a competitive market, focus on equity during ...Breakout Session
- Diversity and Opportunity
-
While CAR-T therapies have revolutionized cancer treatment, access remains largely confined to major academic medical centers, limiting treatment availability for most eligible patients. Expanding del ...Breakout Session
-
Value‚ Patient Access and Reimbursement
-
-
Where there is unmet clinical need, opportunities to develop therapeutics to help the greatest number of patients follow. It is important that the surrounding ecosystem directs biopharmaceutical compa ...Breakout Session
-
Patient Advocacy
Sponsored by:
-
-
In today’s world, successful therapeutic developers must not only generate clinical data to meet regulatory requirements for approval, they must also demonstrate the value of therapeutic candidates to ...Breakout Session
-
Business Development and Investment
Sponsored by:
-
-
Fireside ChatJoin BIO's Chief Patient Advocate and Head of the Patient Advocacy Center of Excellence, Michele Oshman, for a fireside chat with author of "More Than We Expected: Five Years With a Remarkable Child", ...Fireside Chat
-
Patient Advocacy
-
-
Company Presentation SessionCompany Presentation Session
-
Business Development and Investment
Thank you to our Company Presentation sponsors:
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.Loading
-
-
BioProcess International TheaterBioProcess International Theater
-
Biomanufacturing
-
-
Company Presentation
.png)
Repoxegen Therapeutics (a JLabs incubated company) is developing a groundbreaking oral drug that targets a key biochemical path-way enzyme in fatty acid metabolism involved in neuro-inflammation, an i ...Company Presentation- Ophthalmology
-
The BIO Storytelling Stage is a showcase of the heart of BIO's priorities—sharing the stories of the biotechnology industry that show who we are, who we serve, what we do, and why we do it. You'll hea ...Storytelling Stage Storytelling Stage (Booth #349)
-
The EU is reshaping its biotechnology landscape, with the focus on competitiveness, supply and capacity resilience and societal benefit. A European Commission 5 year mandate has over 20 legislations a ...Breakout Session
-
Emerging Opportunities in Global Markets
-
-
Company Presentation
Founded in 2001 and headquartered in Beijing, Youcare Pharmaceutical Group Co., Ltd. is a pharmaceutical conglomerate specializing in R&D, production, circulation, and sales of new drugs. With over 20 ...Company Presentation- Multiple Therapeutics
-
Company Presentation
Vivani Medical (Nasdaq: VANI) is an innovative, clinical-stage biopharmaceutical company developing miniature, ultra long-acting, GLP-1 drug implants by leveraging its proprietary NanoPortal platform ...Company Presentation- Metabolic Diseases
-
Company Presentation
Repair Biotechnologies' platform technology enables rapid clearance of excess intracellular free cholesterol, an undruggable target that contributes to the pathology of many age-related and obesity-re ...Company Presentation- Cardiovascular
Primary Speaker -
BioProcess Session
-
Biomanufacturing
-
-
Fireside ChatIn 2022, Congress tasked the National Security Commission on Emerging Biotechnology with assessing how the United States can maintain its global lead in biotech and safeguard our collective security. ...Fireside Chat
-
Business Development and Investment
-
-
The Storytelling Stage is accessible to all registered attendees. You can find it located in the Exhibition Hall - Booth #349. The BIO Storytelling Stage is a showcase of the heart of BIO's priorities ...Storytelling Stage Storytelling Stage (Booth #349)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.png)
.jpg)
.png)
.jpg)
9:15 AM (ET)
-
Company Presentation
Vasthera Co., Ltd. is a Korea-based pre-clinical stage pharmaceutical company pioneering first-in-class drugs for chronic inflammatory diseases, such as cardiovascular, cancer, eye, and neurodegenerat ...Company Presentation- Cardiovascular
Primary Speaker -
Company Presentation
Imbrium Therapeutics is a privately held clinical stage biopharmaceutical company dedicated to advancing medical science by developing new non-opioid therapies to treat pain, cancer, genitourinary dis ...Company Presentation- Multiple Therapeutics
-
Company Presentation
GelMEDIX is a preclinical ophthalmology company, developing a retinal pigment epithelial (RPE) cell therapy to treat Geographic Atrophy, the leading cause of blindness in American adults. The first an ...Company Presentation- Ophthalmology
Primary Speaker -
Company Presentation
Biolexis Therapeutics is at the forefront of revolutionizing drug discovery, pioneering next-generation targeted metabolic and regenerative therapies through its proprietary AI-enabled platform, Molec ...Company Presentation- Metabolic Diseases
Primary Speaker -
The global inequitable distribution of COVID-19 vaccines has spotlighted the urgent need for localized vaccine manufacturing capacity in Africa. This presentation explores strategic pathways to achiev ...BioProcess Session
-
Biomanufacturing
Speakers -
9:30 AM (ET)
-
Company Presentation
PharmaLogic is a leading global contract development and manufacturing organization (CDMO) specialized in diagnostic and therapeutic radiopharmaceuticals. With decades of industry expertise and a robu ...Company Presentation- Contract Manufacturing Organization
Primary Speaker -
Company Presentation
Fibrosoft: A novel non-surgical treatment of fibromatosis, including Dupuytren’s, Ledderhose’s and Peyronie’s diseases. Introduction: Subcutaneous scarring and contracture affecting the hands (Dupuytr ...Company Presentation- Multiple Therapeutics
-
Company Presentation
.jpg)
Nanoscope strives to provide life-changing therapies for the millions of patients worldwide who are blinded by the most complex retinal diseases with the highest unmet need. This patient-focused cultu ...Company Presentation- Ophthalmology
Primary Speaker -
Company Presentation
OKYO Pharma Limited (NASDAQ: OKYO) is a clinical stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain and dry eye disease, with ordinary shares ...Company Presentation- Ophthalmology
Primary Speaker
9:45 AM (ET)
-
Company Presentation
Dyadic International, Inc., founded in 1979, transitioned from an industrial textiles company to a Nasdaq-listed global biotechnology company focused on microbial platforms for biopharmaceutical and b ...Company Presentation- Respiratory
Primary Speaker -
Company Presentation
King Abdullah International Medical Research Center (KAIMRC) aims to translate laboratory results into impactful healthcare products while cultivating skilled researchers. As a leading research organi ...Company Presentation- Multiple Therapeutics
Primary Speaker -
Company Presentation
TAHO Pharmaceuticals, founded in 2010 in Taipei, Taiwan, and listed on the Taipei Exchange, is dedicated to transforming drug delivery with heart and innovation. We specialize in advanced formulations ...Company Presentation- Cardiovascular
-
Company Presentation
BrilliantStrings Therapeutics' mission is to dramatically accelerate and improve the quality of healing of the toughest connective tissue injuries to bring relief to millions of patients who would oth ...Company Presentation- Regenerative Medicine
Primary Speaker
10:00 AM (ET)
-
Company Presentation
Frontera is a global clinical-stage biotech company dedicated in developing innovative, high-quality, affordable rAAV gene therapies. Our work is backed by global top-notch scientists/KOLs and funded ...Company Presentation- Ophthalmology
-
Company Presentation
-
Start-Up Stadium Session
-
Business Development and Investment
-
-
There are many factors to consider when selecting a chromatography resin for use in a biopharmaceutical purification process. No longer does a singular affinity solution address the needs of increasin ...BioProcess Session
-
Biomanufacturing
-
-
Company Presentation
IMBiologics (IMB) focuses on developing novel treatment options for Immunology & inflammation (I&I) diseases and cancer, utilizing innovative mechanisms of action and/or antibody platform technology, ...Company Presentation- Multiple Therapeutics
Primary Speaker -
Company Presentation
.png)
New epitopes to bind, more ways to fight, more patients to help. Sanavia Oncology Inc. is a Series B stage, venture-backed, New York-based biotech company with a founding team from Rockefeller Univers ...Company Presentation-
Oncology
Primary Speaker -
10:10 AM (ET)
-
Start-Up Stadium-
Orphan and Rare Disease
Primary Speaker -
10:15 AM (ET)
-
This session will discuss why, contrary to conventional wisdom, the need for co-pay and premium assistance, in this complicated environment, is likely to increase, not decrease, under the IRA. Panelis ...Breakout Session
-
Patient Advocacy
-
-
Countless preclinical- and clinical-stage drugs remain shelved, not for scientific reasons or because they lack demonstrated potential to help patients, but rather because of strategic, organizational ...Breakout Session
-
Business Development and Investment
-
-
A new class of conditionally active biologics that is safer and less toxic than existing therapies is emerging. These drugs have the potential to overcome shortcomings of current state-of-the-art ther ...Breakout Session
-
Next Generation Biotherapeutics
Speakers -
-
Emerging modalities are driving the future of the biopharma industry, and pharmaceutical companies are increasingly turning to external sources for these innovations. This panel brings together speake ...Breakout Session
-
Business Development and Investment
Speakers -
-
The industry is still grappling with GenAI while quantum is lurking around the corner. There are already companies and countries experimenting with quantum. From a business perspective, the ways that ...Breakout Session
-
AI and Digital Health
ModeratorSpeakers -
-
New Approach Methodologies (NAMs) are at the forefront of transforming how biomedical research translates into real-world treatments, enabling faster and more precise drug development by, in some case ...Breakout Session
-
Translational Research
Speakers -
-
CAR-T and other advanced therapies hold transformative, and even curative potential, however reimbursement bottlenecks are preventing widespread access. Payer hesitation, regulatory complexity, and ot ...Breakout Session
-
Value‚ Patient Access and Reimbursement
-
-
The Rare Disease Innovation Hub, established by the FDA in 2024, serves as a pivotal point of collaboration between the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Eval ...Breakout Session
-
Orphan and Rare Disease
-
-
In the rapidly evolving landscape of cell and gene therapy, the journey from clinical development to commercial launch presents unique challenges and opportunities. This session will provide attendees ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
Sponsored by:
-
-
Company Presentation
Beijing Sungen Biomedical Technology Co., Ltd is an innovation-driven, clinical-stage biotechnology company founded in 2018, dedicated to advancing human health through cutting-edge technologies. We a ...Company Presentation- Cardiovascular
-
Food is medicine—and yet, for millions, it’s out of reach. Since 2021, the Greater Boston Food Bank has led the way and conducted an annual survey of Massachusetts households to determine the rates an ...Special Program
-
Patient Advocacy
Speakers -
-
“The Next Frontier,” a new branded film series produced by BBC StoryWorks and presented by BIO, explores how biotechnology is shaping the future of health, climate, and food, but if public understandi ...Special Program
-
Next Generation Biotherapeutics
-
-
Company Presentation
PharmAbcine is a clinical-stage public company, founded in 2008 during the global economic crisis with investment from Novartis and OrbiMed. We possess a fully human antibody library, a patient-derive ...Company Presentation- Ophthalmology
-
What makes a partnership work in vaccine development? When is it the right stage to partner programs? How do you identify strategic partner fits? With its own unique ecosystem, vaccine development and ...Breakout Session
-
Infectious Disease and Vaccines
Sponsored by:
)
-
-
Company Presentation
Avalo Therapeutics is a clinical stage biotechnology company focused on the treatment of immune mediated inflammatory diseases. Avalo’s lead asset is AVTX-009, an anti-IL-1β mAb, is a humanized monocl ...Company Presentation- Immunology
Primary Speaker -
Following his fireside chat, join James Robinson for a book signing and meet and greet. Complimentary copies of the books will be available at the signing on a first come, first served basis. Book sig ...Special Program
-
Patient Advocacy
-
-
This interactive session is designed to provide students with the guidance and connections needed to navigate entry into the biotech industry. Panelists will share their personal career journeys and i ...Special Program
-
Business Development and Investment
Speakers -
-
Company Presentation
Pharmacin is a specialty biotech company focused on developing differentiated products across multiple therapeutic areas. The company has two locations, one in Shenzhen, China and New Haven, CT. The l ...Company Presentation- Multiple Therapeutics
Primary Speaker -
Legal challenges, directives from elected and appointed leaders, and public funding reductions have intensified in recent months. How do companies remain compliant and committed to their missions? Wha ...Breakout Session
- Diversity and Opportunity
Moderator
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
10:20 AM (ET)
-
Start-Up Stadium-
Orphan and Rare Disease
Primary Speaker -
10:30 AM (ET)
-
Company Presentation
Cenyx Biotech Inc. is a pioneering nanomedicine company developing first-in-human cerium oxide-based nanozyme for acute and chronic inflammatory diseases with high unmet needs. Our lead candidate, CX2 ...Company Presentation- Inflammation
Primary Speaker -
Company Presentation
Boehringer Ingelheim is an independent company and a global leader in both animal and human health. We focus on delivering breakthrough innovation - wherever it originates - to tackle the most importa ...Company Presentation- Multiline Global Biopharma
-
Riboway Therapeutics is pioneering RNA-targeted therapeutics using an AI-driven platform that decodes RNA regulation to precisely control protein expression—upregulation, downregulation, activation, o ...Start-Up Stadium- Platform for Therapeutics
Primary Speaker -
Company Presentation
Valley Fever Solutions is focused first on a Phase-2-ready therapeutic already shown superior to current drugs to treat Valley Fever (VF, coccidioidomycosis). Nikkomycin Z (NikZ) is an antifungal that ...Company Presentation-
Infectious Disease and Vaccines
Primary Speaker -
-
Company Presentation
Antelope Surgical Solutions is a clinical-stage biotech company developing a patent pending multimodal radioligand-fluorescent platform to improve cancer therapy, imaging and surgery. Our lead compoun ...Company Presentation-
Oncology
Primary Speaker -
.jpg)
10:45 AM (ET)
-
Company Presentation
Elanco is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, v ...Company Presentation- Other
-
Start-Up Stadium- Platform for Therapeutics
Primary Speaker -
Company Presentation
Founded in 2018 as a spin-off from Samsung Medical Center, AimedBio is a clinical-stage biotech company specializing in antibody-drug conjugates (ADCs) and antibody-based cancer therapies. The company ...Company Presentation-
Oncology
Primary Speaker -
-
Company Presentation
Our platform technologies, TROCAD™ and TROSIG™, are expected to improve the therapeutic index by reducing toxicity and improving efficacy simultaneously. TROCAD™ is TriOar's proprietary dual-function ...Company Presentation-
Oncology
Primary Speaker -
10:50 AM (ET)
-
For nearly 20 years, the Bioprocess Technology Group has been tracking the supply and demand for biopharmaceutical manufacturing and will present the manufacturing landscape from 2007 to today, reveal ...BioProcess Session
-
Biomanufacturing
-
11:00 AM (ET)
-
Company Presentation
GenVivo is a private, clinical-stage company with a patented, off-the-shelf vector platform that fights cancer by activating the patient’s own immune system targeting the breadth of the patient’s own ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
As the world’s leading animal health company, Zoetis is driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After innovating ways to predict, prevent, detec ...Company Presentation- Pain Management
-
Start-Up Stadium- Platform for Therapeutics
Primary Speaker -
Company Presentation
Octozi is building AI-powered software to speed up and simplify how new medicines get to market. Today, bringing a drug to patients is a long, expensive process — often taking over a decade and billio ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
Mustbio develops first-in-class and best-in-class, highly tumor-selective immuno-cytokines. Our mission is to precisely harness the power of the immune system, addressing the limitations of convention ...Company Presentation-
Oncology
Primary Speaker -
.jpg)
11:10 AM (ET)
-
Start-Up Stadium- Platform for Therapeutics
Primary Speaker
11:15 AM (ET)
-
Company Presentation
We are a clinical stage company developing a sustained-release drug delivery platform with application across a broad range of conditions, including pain and cancer medications. We have two products i ...Company Presentation- Pain Management
Primary Speaker -
Company Presentation
Umoja Biopharma is a clinical stage, in vivo CAR T cell therapy developer and manufacturerCompany Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company Presentation
Zymeworks is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks’ mission is to make a meaningful differe ...Company Presentation-
Oncology
-
-
Company Presentation
ChromaTan has commercialized the first-ever, column-free, single-use, and steady-state continuous chromatography platform, based on the Real Moving Bed principle that provides dramatic improvements in ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
BioProcess Session
-
Biomanufacturing
-
11:20 AM (ET)
-
Start-Up Stadium- Platform for Therapeutics
Primary Speaker
11:30 AM (ET)
-
Company Presentation
Chimeric Therapeutics is a clinical stage cell therapy company. CHM has four phase 1 clinical trials across three assets. CHM is proud to be developing two Auto-CAR-Ts, one for GI cancers and another ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Super SessionJoin Anjalee Khemlani (Yahoo Finance) in conversation with Mina Makar, RpH (SVP, Global Cardiovascular, Renal and Metabolism, BioPharmaceuticals Business Unit, AstraZeneca) as they explore the transfo ...Super Session
-
Special Program
Sponsored by:
-
-
Company Presentation
MAIA Biotechnology is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended t ...Company Presentation-
Oncology
-
-
The Next Frontier Films: From pandemic preparedness to food security, climate change to resource scarcity, the world requires innovative solutions to the challenges facing society. With its potential ...Storytelling Stage Storytelling Stage (Booth #349)
-
Start-Up Stadium- Platform for Therapeutics
-
Company Presentation
Avenue Biosciences is a transatlantic biotechnology company dedicated to accelerating the discovery and development of protein biologics, so that no life-saving therapy goes unrealized because of prod ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabete ...Company Presentation- Metabolic Diseases
.jpg)
11:40 AM (ET)
-
Start-Up Stadium- Platform for Therapeutics
Primary Speaker -
BioProcess Session
-
Biomanufacturing
-
11:45 AM (ET)
-
Company Presentation
Artiva (NASDAQ: ARTV) is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with autoimmune diseases and cancers. Artiva’s ro ...Company Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company Presentation
Rakuten Medical is a clinical and commercial-stage biotech company advancing its investigational Alluminox™ platform, which is based on photoimmunotherapy. The company is developing the platform consi ...Company Presentation-
Oncology
-
-
Company Presentation
QDX is a drug discovery company specializing in high-performance quantum simulations to accelerate the design of new therapeutics. Founded by experts in life science, computational chemistry, and high ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
.png)
Tiziana Life Sciences is a clinical-stage biopharmaceutical company developing breakthrough therapies using transformational drug delivery technologies to enable alternative routes of immunotherapy. T ...Company Presentation- Multiple Therapeutics
Primary Speaker
11:50 AM (ET)
-
BioProcess Session
-
Biomanufacturing
-
12:00 PM (ET)
-
Company Presentation
Founded by serial entrepreneurs and Harvard professors John Iafrate and David Weitz, Hunter BioDiscovery designed an AI-guided, high-throughput platform called FlowMatrixTM to rapidly assess drug syne ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
.jpg)
GeneQuantum (GQ) has developed a strong pipeline of next-gen of ADCs with wider therapeutic window & higher affordability with its proprietary One-Enzyme-One-Reaction bioconjugation technology (DAR2/4 ...Company Presentation-
Oncology
-
-
Company Presentation
Reprogenix Bioscience’s lead candidate, RGB-5088, is chemically-induced pluripotent stem cell-derived islets (CiPSC-islets) with clinically-demonstrated safety and efficacy for diabetes therapy. Findi ...Company Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company PresentationAI, Automation, and the Data Ecosystem: A Blueprint for the Future of R&D The convergence of AI and automation is reshaping the future of healthcare R&D within a robust data ecosystem. During this pre ...Company Presentation
- Multiline Global Biopharma
12:10 PM (ET)
-
BioProcess Session
-
Biomanufacturing
-
12:15 PM (ET)
-
Company Presentation
.jpg)
Avobis Bio is clinical-stage biotech company developing implantable cell therapies to heal debilitating conditions. We were launched out of the Mayo Clinic in 2019 and our lead asset is in a Phase 2 c ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a ...Company Presentation-
Oncology
-
-
Company Presentation
Genomics is a precision medicine company accelerating target discovery and clinical development through large-scale genomic insights powered by AI/ML-driven analysis. We were formed in 2014 by four gr ...Company Presentation- Tools/Drug Development Support Tech
-
Company Presentation
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most complex health problems. Today, as a member of the Roche Group, we remain dedicated to pursuing breakt ...Company Presentation- Multiline Global Biopharma
12:20 PM (ET)
-
BioProcess Insider Interviews will feature two engaging conversations with Key Opinion Leaders who will share their expert insights on pressing industry challenges. These thought leaders will address ...BioProcess Session
-
Biomanufacturing
-
12:30 PM (ET)
-
Gene therapy is entering a new era. Recent technological breakthroughs are transforming the field, unlocking new possibilities for clinical applications and offering hope for patients with previously ...BioProcess Session
-
Biomanufacturing
Speakers -
-
BioProcess International Theater
12:50 PM (ET)
-
This session will explore the future of bioprocessing through three dynamic 20-minute presentations. The aims of these presentations encompass several cutting-edge developments, focusing on the adopti ...BioProcess Session
-
Biomanufacturing
-
1:00 PM (ET)
-
Eight rare disease families are changing the future of medicine as they pursue their missions to cure the incurable. These inspiring stories of love, loss and determination prove that every one of us ...Storytelling Stage Storytelling Stage (Booth #349)
-
Start-Up Stadium Session
-
Business Development and Investment
-
1:10 PM (ET)
-
Company Description: OsteoCure Therapeutics is a Duke University spinout and JLABS company focused on simultaneously accelerating bone healing while reducing pain.Start-Up Stadium-
Infectious Disease and Vaccines
Primary Speaker -
1:15 PM (ET)
-
The 35th edition of EY’s Beyond Borders Biotechnology Report provides an in-depth look at the US and European biotechnology industry’s standing within a quickly evolving transaction and financing envi ...Breakout Session
-
Business Development and Investment
Speakers -
-
Establishing university-industry partnerships enables the realization of ideas and discoveries to become actual products and services that benefit the public. These partnerships present a variety of o ...Breakout Session
-
Translational Research
Speakers -
-
Hear a diverse panel of small investors (angels and small VCs) from around the world discuss the role of smaller investors in the lifecycle of biotechnology startup companies – both in the US and over ...Breakout Session
-
Business Development and Investment
-
-
Recent data reveals that less than 10% of CEOs in the biopharma industry are women, while female representation in leadership teams stands at 25%. However, the momentum for change is undeniable. A gro ...Breakout Session
- Diversity and Opportunity
Moderator -
Conducting multi-national clinical trials for rare diseases poses ethical and logistical challenges, particularly in ensuring equitable patient access and sustainable commercialization plans. This pan ...Breakout Session
-
Orphan and Rare Disease
Moderator -
-
Integrating real-world evidence (RWE) strategies during drug development and commercialization is critical to maximizing shareholder and stakeholder value. Biopharma executives need to know how to lev ...Breakout Session
-
AI and Digital Health
-
-
In vivo CAR (Chimeric Antigen Receptor) therapies are poised to revolutionize immunotherapy by moving beyond the limitations of traditional ex vivo approaches. These therapies involve programming immu ...Breakout Session
-
Next Generation Biotherapeutics
-
-
Biotech goes beyond science - although the building blocks of our industry are made up of groundbreaking approaches that start in the lab, the goal is that they end in one place - impacting patients. ...Breakout Session
-
Patient Advocacy
Speakers -
-
This interactive session is designed to provide students with the guidance and connections needed to navigate entry into the biotech industry. Panelists will share their personal career journeys and i ...Student Program 209ModeratorSpeakers
-
Super SessionCDMOs play a pivotal role in the rapidly evolving landscape of the pharmaceutical and biotechnology industries, helping them bring innovative therapies and life-saving products to market. Over the nex ...Super Session
-
Special Program
Sponsored by:
-
-
Breakthroughs in biomanufacturing, biochemical modeling, and AI-enabled drug discovery and development could dramatically boost industry-wide productivity—but they require massive early-stage investme ...Special Program
-
Biomanufacturing
Speakers -
-
Biotechnology supply chains are inherently global, spanning research, development, manufacturing, distribution, and skilled workforce networks across multiple countries. This interdependence has drive ...Breakout Session
-
Emerging Opportunities in Global Markets
-
.jpg)
.png)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
1:20 PM (ET)
-
Start-Up Stadium- Regenerative Medicine
Primary Speaker
1:30 PM (ET)
-
Start-Up Stadium- Regenerative Medicine
Primary Speaker -
BioProcess Session
-
Biomanufacturing
-
1:45 PM (ET)
-
Company Presentation
RESTEM is a leading clinical-stage biotechnology company focused on developing off-the-shelf, next-generation cell therapies designed to modulate the immune system. Leveraging our proprietary products ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
Gain Therapeutics, Inc. is a clinical-stage biotechnology company leading the discovery and development of next generation allosteric therapies. Gain’s lead drug candidate, GT-02287 is currently being ...Company Presentation- Other
-
Company Presentation
Qubigen is an exciting new venture that combines Federated AI technology, quantum chemistry and AI drug design capabilities. Qubigen’s mission is to create the largest global federated proprietary dat ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
The founders of Alera Therapeutics have developed neural stem cells for the treatment of nervous system disorders including gastrointestinal motility disorders and peripheral nerve injury.Start-Up Stadium
-
Cell and Gene Therapy and Genome Editing
Speakers -
-
Company PresentationNovartis Contract Manufacturing is a global contract manufacturing player in the biotech field and cell & gene therapy offering world class manufacturing services in the Novartis state of art faciliti ...Company Presentation
- Contract Manufacturing Organization
Primary Speaker
.jpg)
.jpg)
.jpg)
2:00 PM (ET)
-
Company Presentation
Biosyngen, a biotechnology company headquartered in Singapore that focuses on unmet therapeutic needs in cancer patients. Biosyngen develops first-in-class immunotherapy-based strategies to provide ca ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
CELLTRION was established in 2002, starting as a small CMO start-up company. Within just 20 years, we grew to become a global biopharmaceutical company with Sales profit reaching up to nearly 3 billio ...Company Presentation- Other
Primary Speaker -
Company Presentation
At CytoTronics, we are transforming cell biology discovery with our high-throughput, semiconductor-based platforms. Our Pixel systems provide live cell insights with single-cell resolution across all ...Company Presentation- Tools/Drug Development Support Tech
-
Company Presentation
Please see company description in partnering systemCompany Presentation- Multiline Global Biopharma
-
3Daughters is focused on Women’s Health with an innovative uterine delivery system. Our first product is a frameless nonhormonal IUD for contraception designed to conform to a woman’s body. Combined w ...Start-Up Stadium- Reproductive/Sexual Health
Primary Speaker -
BioProcess Session
-
Biomanufacturing
-
.png)
2:10 PM (ET)
-
Start-Up Stadium- Tools/Drug Development Support Tech
Primary Speaker
2:15 PM (ET)
-
Company Presentation
-
Company Presentation
Resolution Therapeutics is a clinical-stage biopharmaceutical company pioneering regenerative macrophage therapy in inflammatory and fibrotic diseases. The Company leverages its proprietary platform t ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
Nxera Pharma is a technology powered biopharma company in pursuit of new specialty medicines to improve the lives of patients with unmet needs in Japan and globally. We have built an agile, new-genera ...Company Presentation- Multiple Therapeutics
-
Company Presentation
IXICO is dedicated to delivering insights in neuroscience to help transform the advancement of investigational therapies for neurological diseases, such Alzheimer's disease, Parkinson’s disease and Hu ...Company Presentation- Contract Research Organization
Primary Speaker
2:20 PM (ET)
-
Start-Up Stadium- Tools/Drug Development Support Tech
Primary Speaker
2:30 PM (ET)
-
Won an SBIR/STTR grant from the NIH for your biomedical innovation? A new paradigm for inter-agency, industry, and venture capital collaboration is here to help commercialize it! Startups are 50% more ...Breakout Session
-
Business Development and Investment
ModeratorSpeakers -
-
This session will delve into the intricate landscape of the US legal and regulatory framework governing the use of artificial intelligence (AI) in pharmaceutical product development. As AI continues t ...Breakout Session
-
Regulatory Innovation
-
-
Rare disease clinical trials face unique challenges, including small patient populations, high variability in disease presentation, and logistical complexities. This panel will explore innovative stra ...Breakout Session
-
Orphan and Rare Disease
ModeratorSpeakers -
-
With the development of RNA therapeutics advancing at an unprecedented pace, the healthcare and pharmaceutical industry is entering an “RNAissance” era. RNA, a molecule that was viewed as a transient ...Breakout Session
-
Next Generation Biotherapeutics
Speakers -
-
Computational methods including AI/machine learning have the potential to be transformational in biopharma by accelerating and enhancing many aspects of drug discovery to bring better drug candidates ...Breakout Session
-
AI and Digital Health
Speakers -
-
Whether setting a course or changing strategies in today's biopharma landscape, information overload, quickly obsolete insight, and stakeholder misalignment are industry-wide challenges. As an emergin ...Breakout Session
-
Business Development and Investment
Speakers -
-
Since 2008, Massachusetts has made significant financial, policy, and people investments in the life sciences, including building a broad-based effort to expand pathways to produce diverse talent to d ...Breakout Session
- Diversity and Opportunity
ModeratorSpeakers -
While huge advances have been made in ensuring optimal patient care in oncology where diagnostic testing is required prior to initiation of therapy (i.e. precision medicine), we continue to see practi ...Breakout Session
-
Diagnostics and Personalized Medicine
Speakers -
-
Company Presentation
Yokogawa founded in Tokyo, Japan in 1915 is a global leader in industrial automation and control, test and measurement, information systems, and industrial services. With our experience of innovation ...Company Presentation- Tools/Drug Development Support Tech
Primary Speaker -
The Foundation for the NIH (FNIH) creates and leads alliances and public-private partnerships that advance breakthrough biomedical discoveries and improve the quality of people’s lives. Building on a ...Breakout Session
-
Business Development and Investment
-
-
Start-Up Stadium- Tools/Drug Development Support Tech
Primary Speaker -
Company Presentation
We are a private, clinical stage biotech in the therapeutic area of Women's Healthcare and Urology, bladder conditions which primarily affect women. We have 2 phase 2 assets, one with an ongoing funde ...Company Presentation- Other
Primary Speaker -
BioProcess Session
-
Biomanufacturing
Speakers -
-
Company Presentation
Medera Inc. is a clinical-stage biotechnology company focused on developing treatments for difficult-to-treat cardiovascular diseases through next-generation AAV gene therapy. We leverage our bioengin ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
America risks falling behind in biotechnology because it hasn't treated the sector as a strategic priority—unlike semiconductors or AI. For example, the currently fragmented and opaque regulatory syst ...Special Program
-
Regulatory Innovation
-
-
The Asia Pacific region is rapidly becoming a global force in healthcare and biotech innovation—fueled by resilient capital flows and propelled by its rising scientific capabilities, diverse patient p ...Breakout Session
-
Emerging Opportunities in Global Markets
Sponsored by:
-
-
Super SessionOn May 12, 2025, the Trump Administration announced a new Executive Order, “Delivering Most Favored Nation Prescription Drug Pricing to American Patients.” This was followed by an announcement on May ...Super Session
-
Special Program
-
-
Emerging companies are the lifeblood of biotech innovation. Over time, the share of FDA-approved therapies originating from small and mid-sized biotech companies has grown steadily, now accounting for ...Special Program
-
Special Program
-
-
Company Presentation
Prazer is a Korean biotech company developing orally available, blood-brain barrier (BBB)-penetrating protein degraders through a novel approach to targeted protein degradation (TPD). Since our incept ...Company Presentation- Multiple Therapeutics
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpeg)
.jpg)
.jpg)
.png)
.jpg)
.jpg)
2:45 PM (ET)
-
Company Presentation
Curocell is a commercial-stage cell therapy company spanning from development to commercial manufacturing. Our mission is to transform cancer treatment by developing innovative, robust, and scalable c ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
-
Company Presentation
Daré Bioscience is a biopharmaceutical company driven by a mission to challenge the status quo, making women's health a priority. We believe that innovation does not have to start from scratch. Our go ...Company Presentation- Reproductive/Sexual Health
Primary Speaker -
Company Presentation
Kolon TissueGene (KOSDAQ: 950160) specialize in developing advanced treatments for degenerative joint and spinal diseases, including osteoarthritis and degenerative disc disease, based on innovative c ...Company Presentation- Regenerative Medicine
Primary Speaker -
Company Presentation
Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines (biologics, vaccines, nucleic acid, cell/ gene therapy modalities and drug product). Fou ...Company Presentation- Contract Manufacturing Organization
Primary Speaker
.jpg)
3:00 PM (ET)
-
Company Presentation
Accelerated Biosciences is a regenerative medicine company commercializing the human Trophoblast Stem Cell (hTSC). hTSCs are the earliest stem cells that can be sourced without ethical issues. The hol ...Company Presentation- Regenerative Medicine
Primary Speaker -
Company Presentation
TiCARos is a clinical-stage South Korean biotech company developing next-generation CAR-T and CAR-NK cell therapies to overcome the limitations of current immunotherapies. We leverage two proprietary ...Company Presentation-
Cell and Gene Therapy and Genome Editing
-
-
Company Presentation
LIfT BioSciences is a UK and Ireland-based biotech pioneering the world’s first neutrophil-based cell therapy platform, N-LIfT. This allogeneic platform produces Immuno-Modulatory Alpha Neutrophils (I ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
3:15 PM (ET)
-
Company Presentation
Junevity is a longevity biotechnology company developing Cell Reset therapeutics, a new class of medicines reversing transcriptional damage with siRNA. Junevity’s RESET platform is the first to use la ...Company Presentation- Regenerative Medicine
Primary Speaker -
Company Presentation
With our mission, team, and our technology we are committed to driving innovation, improving patient outcomes, and shaping the future of cardiovascular medicine.Our platform technology for AAV vectors ...Company Presentation-
Cell and Gene Therapy and Genome Editing
Primary Speaker -
.png)
3:30 PM (ET)
-
Emmy winner, Super Bowl Champion and Peabody award winning journalist Michael Strahan currently co-anchors ABC’s “Good Morning America,” serves as an analyst for “Fox NFL Sunday,” and hosts ABC’s prim ...Featured Program
-
Special Program
-
9:00 AM (ET)
-
Currently, the biotech M&A market is subject to a confluence of unique historic forces, both promoting and opposing M&A. Some of these forces include unprecedent M&A demand from big pharma due to the ...Breakout Session
-
Business Development and Investment
Moderator -
-
The Accelerated Approval Program has been the focus of many recent conversations questioning the impact and value of the pathway for patients. Drugs approved via this pathway have become the latest vi ...Breakout Session
-
Value‚ Patient Access and Reimbursement
Speakers -
-
The global immunology market is projected to nearly double by 2032, expanding from $250 billion in 2023. Immunology and Inflammation (I&I) has now emerged as a top investment priority in biopharma, su ...Breakout Session
-
Next Generation Biotherapeutics
-
-
In recent years, "patient-centric" has emerged as a buzzword in the healthcare world. However, the reality is that our industry has often overlooked the patient voice, which has, at times, impeded the ...Breakout Session
-
Regulatory Innovation
-
-
This session will delve into how preclinical human data, derived from innovative methodologies such as organ-on-a-chip technology, lab-grown tissues, and advanced imaging techniques, can provide inval ...Breakout Session
-
AI and Digital Health
-
-
An increasing number of cell and gene therapies hold significant promise, but challenges remain in bringing these therapies to patients. These include regulatory, manufacturing and clinical trial chal ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
-
-
Company Presentation SessionCompany Presentation Session
-
Business Development and Investment
Thank you to our Company Presentation sponsors:
We're sorry, but we couldn't find any results that match your search criteria. Please try again with different keywords or filters.Loading
-
-
Spilled Milk - Two lifelong friends. Omar is living with Sickle Cell Disease; Jaqai has uprooted his life to make a documentary about him. Spilled Milk explores the harsh realities of Sickle Cell, bey ...Storytelling Stage Storytelling Stage (Booth #349)
-
The Storytelling Stage is accessible to all registered attendees. You can find it located in the Exhibition Hall - Booth #349. The BIO Storytelling Stage is a showcase of the heart of BIO's priorities ...Storytelling Stage Storytelling Stage (Booth #349)
.jpg)
.jpg)
.jpg)
10:00 AM (ET)
-
Start-Up Stadium Session
-
Business Development and Investment
-
10:10 AM (ET)
-
Start-Up Stadium-
Oncology
-
10:15 AM (ET)
-
When innovating toward solutions for the world's greatest health challenges, such as matters of health security, global preparedness, and life-saving health solutions more broadly, time is of the esse ...Breakout Session
-
Regulatory Innovation
-
-
How can obesity treatments move beyond GLP-1 drugs to offer long-term, patient-friendly solutions? Obesity management is at a pivotal phase, with new opportunities emerging to deliver sustainable weig ...Breakout Session
-
Next Generation Biotherapeutics
Speakers -
-
Immunology is entering a new era, presenting unique investment prospects as therapeutic innovations emerge and investors are eager to participate in this attractive field. Next generation I&I therapie ...Breakout Session
-
Business Development and Investment
Speakers -
-
As the pharmaceutical industry increasingly embraces AI in drug discovery, a pressing question emerges: can AI go beyond merely delivering faster and cheaper drugs? Join our expert panel of C-level ex ...Breakout Session
-
AI and Digital Health
-
-
The Inflation Reduction Act (IRA) has caused strong disruption to innovation in drug development, and this impact is falling heaviest on oncology and neuroscience. Cancer drug development has been rem ...Breakout Session
-
Value‚ Patient Access and Reimbursement
Speakers -
-
Company Presentation
Syntis Bio is a clinical-stage biopharmaceutical company developing oral therapies that harness the small intestine’s unique biology to provide more accessible, effective and sustainable solutions acr ...Company Presentation- Metabolic Diseases
Primary Speaker -
The recent landmark success of gene-edited porcine kidney transplants into human recipients marks a turning point in the future of organ transplantation. With genetic engineering enabling immune-compa ...Breakout Session
-
Business Development and Investment
ModeratorSpeakers -
-
With more than 30 approved gene and cell therapy (GCT) products and the rapid emergence of new GCT technologies, academic medical centers (AMCs) play a crucial role in advancing genetic medicines. How ...Breakout Session
-
Cell and Gene Therapy and Genome Editing
Speakers -
-
Super SessionWhether it is FDA, tariffs, interest rates or geopolitical uncertainty, the macro has been exerting significant pressure on the biotech industry. Will there be widespread consolidation in the number o ...Super Session
-
Special Program
Speakers -
-
Company Presentation
Actym is a clinical-stage biotech company that has developed a platform called STACT - a novel therapeutic modality that harnesses the power of genetically modified bacterial vehicles. Our technology ...Company Presentation-
Oncology
Primary Speaker -
-
Successful collaborations among biopharmaceutical companies, patient advocacy organizations, and other key stakeholders help to de-risk drug development and can avoid potentially perilous roadblocks l ...Breakout Session
-
Patient Advocacy
ModeratorSpeakers -
-
AI holds immense promise for helping us bring medicines to patients faster, but only if we confront the growing data dilemma. Specifically, as we aim for AI to impact each step of the drug discovery a ...Breakout Session
-
AI and Digital Health
Sponsored by:
ModeratorSpeakers -
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
.jpg)
10:30 AM (ET)
-
Company Presentation
CorriXR Therapeutics is an oncology-focused biotherapeutics company developing genetic medicines to transform the treatment of solid tumors. CorriXR uses a proprietary in vivo gene editing tool to dis ...Company Presentation-
Oncology
-
-
.jpg)
Start-Up Stadium-
Oncology
-
-
Company Presentation
JD Bioscience is an innovative, clinical-stage pharmaceutical company based in South Korea, specializing in the discovery and development of novel therapeutic compounds targeting diseases with high un ...Company Presentation- Metabolic Diseases
Primary Speaker
10:45 AM (ET)
-
Company Presentation
.png)
InnoCure Therapeutics is a global biopharmaceutical company dedicated to the discovery and development of novel drugs based on next-generation Target Protein Degradation (TPD) mechanisms applicable to ...Company Presentation-
Oncology
-
-
Start-Up Stadium-
Oncology
Primary Speaker -
-
Company Presentation
.png)
PSC Biotech® is a global company that offers essential services to the life sciences industry, such as auditing, consulting, validation, and regulatory support. Founded in 1996, PSC Biotech® has spent ...Company Presentation- Contract Manufacturing Organization
11:00 AM (ET)
-
Company Presentation
Psy Therapeutics discovers and develops innovative medicines for neuropsychiatric and neurological disorders, including PTSD, depression, Chronic Pain, Alzheimer’s, and Parkinson’s. Our robust pipelin ...Company Presentation-
Brain Health
Primary Speaker -
-
Start-Up Stadium-
Oncology
Primary Speaker -
-
Company Presentation
bYoRNA is a biotech platform specializing in the production of therapeutic mRNA using recombinant yeast. Yeast can produce long mRNA (up to 14,000 nucleotides) ideal for gene editing and cell reprogra ...Company Presentation- Platform for Therapeutics
Primary Speaker
11:10 AM (ET)
-
Start-Up Stadium-
Oncology
Primary Speaker -
11:15 AM (ET)
-
Company Presentation
Vincere Biosciences is a precision medicine company advancing small molecule therapeutics that enhance mitophagy, a fundamental cellular repair process with the potential to reverse neurodegeneration ...Company Presentation-
Brain Health
Primary Speaker -
11:20 AM (ET)
-
.png)
Start-Up Stadium-
Oncology
-
11:30 AM (ET)
-
Company Presentation
Biogen International Region over the past 5 years has garnered expertise in rare diseases across a large geographical footprint. Our region provides access to the underserved population in critical ra ...Company Presentation-
Orphan and Rare Disease
-
-
Company Presentation
Oragenics is a clinical stage biotechnology company focused on developing intranasal therapeutics for neurological disorders, including its lead candidate, ONP-002, entering Phase II clinical studies ...Company Presentation-
Brain Health
-
-
Start-Up Stadium-
Oncology
-
.jpg)
11:40 AM (ET)
-
Start-Up Stadium-
Oncology
Primary Speaker -
11:45 AM (ET)
-
Company Presentation
Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening disease ...Company Presentation-
Orphan and Rare Disease
-
-
Company Presentation
Ananda Scientific is a research-driven biotech company developing life-changing medicines to transform neuropsychiatric health. Our lead program is PTSD where we have two well powered phase-2 PTSD cli ...Company Presentation-
Brain Health
Primary Speaker -
11:50 AM (ET)
-
Start-Up Stadium- Respiratory
12:30 PM (ET)
-
Are the nationalist trends toward investment, trade and national security policies going to divide the world into different spheres of R&D and access to health care products? What impact will they hav ...Special Program
-
Special Program
ModeratorSpeakers -
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}